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Mass spectrometry has entered the biology and biochemistry laboratories since the end of the 
1980’s with the introduction of MALDI and ESI as powerful ionization sources. These ion 
sources provided instruments with ability to produce ions of biological molecules with high 
efficiency, and thus allowed the analysis of high molecular weight biomolecules. The most 
routinely used technique relies on the measurement of the mass of peptides within a peptide 
digest, allowing efficient identification of proteins, provided a protein or genomic database is 
available. The peptide sequencing capabilities provided by MS/MS instruments allows the 
gain of sequence information on t hese peptides which can then be used to confirm 
identification, even in complex situations such as in the presence of protein post-translational 
modifications (PTM analysis). But these “soft” ionization techniques have also been shown 
to allow resolving large intact macromolecular assemblies, including large protein 
complexes. Thus mass spectrometry can be used as a tool not only for protein identification 
and characterization but also for protein structure analysis. The major advantage of mass 
spectrometry in this area relies on the extreme sensitivity of the mass measurements: 
although it is s destructive technique, only minute quantities (on the order of 10 atomoles) of 
biological material are required to perform an analysis on t he most sensitive instruments 
currently available. 
Another major advance in mass spectrometry has been the huge increase in mass resolving 
power and mass accuracy. Prior to the 2000, only FT-ICR instruments could provide routine 
resolutions over 100 000 and mass accuracy on the order of 1 ppm. The development of the 
Orbitrap™ mass analyser by Thermo has been a major breakthrough, allowing high mass 
accuracy and high resolution for much less cumbersome instruments. Currently, ESI-TOF 
analyzers are also in constant progress and mass accuracies on t he order of 1 ppm  are 
routinely achieved on a range of instruments. It is thus of interest to develop techniques that 
make use of established protocols but also include increased mass accuracy and high 
resolution in the protocol. 
The development of improved techniques is not a goal in itself, and a mass spectrometry 
technique has to demonstrate its problem-solving capabilities to be widely used. Thus this 
thesis has also relied on attempts to gain insights in a major pathway in biology, protein 
synthesis. The initial aim was to focus on eIF3, one of the protein complexes involved in 
translation initiation: translation initiation involves a number (on the order of 10 for simple 
eukaryotic systems) protein complexes which interact together in a w ell-orchestrated 
molecular machinery, opening the way for efficient and accurate expression of proteins from 
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the mRNA. The eIF3 complex is itself a heteromultimeric protein complex, comprised of 5 
stoechiometric units in the budding yeast Saccharomyces cerevisiae and on the order of 13 
subunits in Homo sapiens. The crystal structure of this large (around 300 kDa) complex is not 
known yet, and only partial information is available on t he assembly of subunits together. 
Even the contact regions between some subunits remains to be solved, and this seemed a 
good system on which to apply the mass spectrometry methods based on the measurement of 
amide H/D exchange (HDX) as developed in the DCMR group at the Ecole Polytechnique in 
the past years. 
Thus this manuscript is organized to reflect the major advances undergone in the course of 
this three year work. In a first introductive part, a summary the key problems tackled in this 
thesis are presented. In a first chapter, the current status on the uses of mass spectrometry for 
protein complex analysis is reviewed. A focus is put on the HDX methods, which represent 
the core of the work presented in this thesis. The standard protocol is presented and discussed 
and recent developments, including the uses fragmentation techniques to gather improved 
resolution on s ite-specific exchange rate constants will be surveyed. In a second chapter, a 
review of the literature concerning the eukaryotic translation initiation factor is done. This 
review puts in perspective the current work with both prior knowledge, and also advances 
that occurred in the course of the thesis, including a crystal structure of partial domains which 
are very close to one of the systems that has been studied in the course of this work. Finally, 
the chapter will focus on the experimental procedures for the production of the protein 
complexes used in this work. 
In a second part, the experimental results gathered throughout this work will be presented. 
This part is itself separated in two. Chapter 3 de als with the methodological developments 
that have been required to increase the size of complexes that could be addressed. As will be 
shown, the increase in size of the protein complexes made that mass accuracy alone was not 
sufficient to correctly assign each isotope distribution to a single peptide. In these conditions, 
the standard procedure would have been inclusion of an MS/MS step to validate individually 
each peptide. But after a change in instrumentation, we noticed that on the newer mass 
spectrometers, sensitivity gains led to the detection of a vastly increased number of peptides. 
Individual validation of each of these peptides was a tough task, and we sought alternatives to 
the MS/MS validation step. The major limitation arises from the lack of specificity of pepsin 
in conditions used for HDX mass spectrometry. But using prior work of another group, we 
devised a predictive tool that can assign a statistical score to each putative peptide, which we 
4
termed “Probability of occurrence” (POc). Combining this score with high mass accuracy, it 
seemed possible to correctly assign peptides without requiring MS/MS validation. Of course, 
in order to demonstrate the validity of this POc scoring system, a thorough comparison of 
datasets with the MS/MS reference method has been performed, and showed very few 
instances for which the POc / accurate mass combination led to falsely assigned peptides. As 
a consequence of this method, it should also be noted that not requiring MS/MS validation 
allows inclusion of a much larger number of peptides within the reference dataset: as noticed 
in this work as well as in earlier work, pepsin digest peptides do not necessarily fragment as 
well in collision induced dissociation conditions as the more common tryptic peptides usually 
present in proteomics studies. Thus a number of peptides are present in the sample but are not 
taken into account when an MS/MS validation step is required because their fragmentation 
results are not sufficient to meet the validation criteria. 
In addition to this central technical development, this chapter will also deal with other 
improvements that have been performed on the processing of the data. The huge datasets that 
are obtained from nano-LC/FT-ICR MS cannot be manually processed. An in-house 
developed software has been used to automate the task of spectrum analysis as much as 
possible. The whole workflow is described and the critical steps which still require manual 
intervention of the scientist are identified and the limitation of automation for these steps will 
be discussed in this chapter. 
Chapter 4 is devoted to the biological results achieved in the course of this thesis on the eIF3 
subunits interaction domain. The first system which will be discussed is the eIF3i:bC3 
interaction region. In 2012, a crystal structure of this binding region was obtained while HDX 
MS data was acquired in our group. Although a bit disappointing since we expected to be 
able to determine the interaction region based on HDX MS measurements, this comparison 
structure allows a good critical discussion on the HDX results for this system. Furthermore, 
this crystal structure also helped a lot in providing a first proposed structure for the eIF3i 
subunit. The existence of this structure helped a lot in the discussion of the results for the 
other system which was explored in this thesis, the eIF3i:gC1ΔC binding region, which will 
constitute the second part of this chapter. Unfortunately, at the time of writing this 
manuscript, only preliminary results are available on the eIF3i:b:g ternary complex: thus only 
a sketch of the global interaction region between the three subunits will be presented in this 
manuscript. 
5
In a final part, the manuscript will present a complete material and methods section. It must 
be pointed out that in the course of this work, the auther had the opportunity to work in close 
collaboration with two groups: in the biochemistry laboratory (Laboratoire de Biochimie), all 
the steps required for obtaining the biological samples were performed, which included 
protein expression, purification, production and purification of the protein complexes. In the 
mass spectrometry laboratory (Labratoire des Mécanismes Réactionnels), the HDX kinetics 
as well as the mass spectrometry analysis and data processing were performed. This leads to a 
very complete work, and all the relevant protocols as well as the technical details are 
provided in this manuscript. 
6
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Before the development of the so-called “soft-ionization” techniques, mass spectrometry (MS) 
was used exclusively in the field of small molecules for the elucidation of unknown 
molecular composition. When it comes to the late 1980s, the development of “soft” 
electrospray ionization (ESI) and matrix assisted laser desorption/ionization (MALDI) 
techniques opened the door of biological MS, as bio-macromolecules can be transferred into 
the gas phase as intact ions, thereby making them amenable to detection by different types of 
mass analyzers. [1-4] Since then, mass spectrometry has been an indispensible tool in the 
development of proteomics study. According to the introductory book of Proteomics, [5] five 
categories of experiments can be considered as applied MS in proteomics: (1) protein 
identification, (2) protein quantitation or differential analysis, (3) post-translational 
modifications (PTMs), (4) protein-protein interactions, and (5) structural proteomics.  
Among all the above aspects, MS is most commonly known for its capacity to identify 
proteins and monitor post-translational modifications (PTMs). Thanks to the large amount of 
protein sequence data available, the identification of several thousand proteins in a single 
study can nowadays be achieved upon a database search using the MS and MS/MS data from 
tryptic (or other protease) peptides. When this technology is applied carefully and correctly, 
the rapid, accurate, sensitive and reproducible characters that modern MS has shown in 
protein identification make it accepted as the routine method for such topics, and bring the 
broad expectations to generate high-coverage to complete proteome maps. [5-7] In the PTMs 
strategies, types and sites of modifications are identifiable for single or multiple protein(s). 
While typical bottom-up approach has been the most widespread method for standard PTMs 
study, complementary methods are also introduced with interesting performances. Top-down 
approach, though they require more advanced instrumentation and data processing software, 
can provide a more comprehensive overview of the protein sequence and the PTM pattern, 
where as middle-down approach that uses proteases cleaving less frequently-occurring amino 
acid residues to generate long peptides (5-6 kDa) has attracted increasing interests as it is 
particularly suitable to focus on regions in which major modifications reside. [8-9] With the 
still undergoing developments of these methods, the proteomic-scale study on PTMs and 
PTMs changes in biological processes has started to grow.  
This work, on the other hand, focuses on another domain of proteomics studies, namely the 
structural proteomics. This involves the fundamental structure determination of proteins, as 
well as the dynamics and structural changes that proteins may undergo due to different 
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factors, e.g. the interaction with ligands, other proteins, the conformational changes during 
various physiological processes, etc. 
1 The structure of proteins 
Proteins are extremely complex molecules. Biochemists define the protein structure into 
several levels (Figure 1): primary structure refers to the amino acid (AA) sequence that forms 
the polypeptide. As the peptide chain folds, it forms certain localized arrangements of 
adjacent (but not necessarily contiguous) AAs that constitute secondary structure. The three-
dimensional (3D) shape that the peptide chain assumes is termed the tertiary structure. When 
consisting of more than one polypeptide chains the protein has a quaternary structure. [10] 
 
Figure 1 Brief illustration of 4-level protein structures. [11] 
1.1 The secondary structure: α-helix, β-sheet and motif 
In the secondary structure of proteins, peptide chains can fold into several repeating patterns. 
The most widely observed patterns are the α-helix and the β-pleated sheet. Both of them are 
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stabilized by localized hydrogen bonding between the carbonyl and N-H groups in the 
peptide backbone. 
The α-helix is a rigid, rodlike structure that forms when a polypeptide chain twists into a 
right-handed helical conformation. Hydrogen bonds form between each N-H of amide group 
and the carbonyl group of the amino acid four residues away, while side chains extend 
outward of the helix. Each turn in the helix consists of 3.6 residues and the distance between 
the same positions of two turns is 0.54 nm.  
β-sheets are formed when two or more peptide chains line up side by side, with each chain 
segment termed as β-strand. The stabilizing hydrogen bonds form between the backbone 
amide N-Hs and the carbonyl groups in the adjacent chains. β-sheets can be either parallel, 
with both chains N-C oriented in the same direction, or anti-parallel with the two chains 
oriented heads to tail. 
Combinations of several α-helix(es) and the β-pleated sheet(s) structures form the so-called 
supersecondary structures or motifs, e.g. the βαβ unit with two parallel β-sheets connected by 
an α-helix, or the β-meander unit with two or more consecutive antiparallel β-sheets linked 
together by direction-reversed hairpin loops. These structures are usually stabilized by 
hydrophobic interaction involving the side chains.  
1.2 The tertiary structure: protein folding process 
As globular proteins fold into their unique native structures and prosthetic groups, if any, are 
inserted, they assume the tertiary structure. The formation process, protein folding, makes 
highly organized structures out of nascent polypeptides. This process occurs as a 
consequence of the interactions between the AAs side chains. Main interactions that stabilize 
tertiary structure include: 1) hydrophobic interactions, when hydrophobic side chains are 
brought closer as they are excluded from water, while highly ordered water molecules are 
released from the interior of the tertiary structure. Yet a few water molecules may remain 
within the core of the folded protein and form up to 4 h ydrogen bonds with the peptide 
backbones and increase the flexibility of some of the internal interactions, which may be 
crucial in the binding of ligands. 2) electrostatic interactions, involving the strong interactions 
between ionic groups of opposite charge (salt bridges) in water-free regions, and weak 
interactions between ion-dipole, dipole-dipole, etc. These interactions can be significant in 
holding the interiors of the tertiary structure, as well as contributing to the interactions of the 
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subunits/ligands in the quaternary structure, as will be discussed later. 3) hydrogen bonds, 
which is not only the stabilization factor in the secondary structure, but also important and 
often observed in the interior and surface of the globular proteins. 4) covalent bonds, most 
prominently the disulfide bridges in many extracellular proteins, are significant in protecting 
proteins from adverse changes in pH or salt concentrations. 5) hydration, i.e. the dynamic 
hydration shells formed around the tertiary structures.   
1.3 The quaternary structure: protein complex and assembly 
A lot of proteins, especially those with high molecular weights, contain more than one 
polypeptide chains (subunits), and these subunits can be either identical or different. The 
quaternary structures, similar to the tertiary structures, are stabilized either by noncovalent 
interactions such as the hydrophobic effect, electrostatic interactions and hydrogen bonds, or 
by covalent cross-links such as disulfide bridges. It is worth noticing that the assembling of 
subunits is often triggered by a conformational change that is affected by the binding of 
ligands, and such conformational change is called allosteric transition.  
2 Probing protein structure by mass spectrometry 
Protein structures, as well as the formation and transition of protein structures, are essential to 
the understanding of various protein functions and metabolic processes. Proteins expressed in 
living organisms mostly function in the form of protein complexes, which are further 
organized in protein interaction networks in the living cell. [12] In order to understand the 
function of a protein, it is of great importance to obtain comprehensive knowledge of its 
structure and dynamics on the molecular level and preferably in its native state, i.e. in the 
solution phase, in a medium close to the cellular content. Structural MS has drawn increasing 
attentions and shown great successes on t hese topics since the introduction of ion sources 
adapted for biomolecules. Typical structural MS techniques includes affinity purification 
mass spectrometry (AP-MS), chemical cross-linking mass spectrometry (CX-MS), MS of 
intact assemblies (native MS), and labeling techniques such as hydroxyl radical labeling and 
hydrogen/deuterium exchange mass spectrometry (HDX-MS).  
2.1 AP-MS 
AP-MS uses the affinity purification technique, one that has been commonly applied by 
biochemists. In AP, the protein of interest and its associated interactors are selectively 
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purified using either antibodies targeted towards this protein or an affinity tag introduced in 
the protein of interest. After pull down the proteins present are then analyzed and identified 
by proteomics-based MS (Figure 2 D). [13-15] Using AP-MS, it is  therefore possible to 
investigate the connectivity within a complex or establish whole protein interaction networks. 
AP-MS is nowadays probably the method of choice when looking at protein-protein 
interactions on a  global scale. With the application of the powerful tandem affinity 
purification (TAP) protocols and the integration of other strategies such as quantitative 
interaction proteomics, elegant works have been reported on s olving large-scale protein 
network architecture, for example the stoichiometry and architecture of the cullin-RING 
ubiquitin ligase network was revealed by a study which combined AP-MS with multiplex 
absolute quantification technology. [16]  
2.2 Native MS 
In native MS, intact complexes of up t o several MDa are no l onger hydrolyzed as in 
conventional MS-based proteomics studies, but directly ionized and analyzed by mass 
spectrometry (Figure 2 E). By careful manipulation of the experimental conditions of 
pressure and accelerating voltages, the target protein assembly can be ionized in the intact 
form as a whole without dissociation in the travel through the instrument. [12, 17-18] The 
overall stoichiometry is the initial information obtainable from the native MS, yet the 
connectivity of the different subunits are also important information achievable when partial 
dissociation is performed in controlled conditions. Native MS is often combined with 
proteomics MS to identify each of the subunits in the assembly, ion mobility to understand 
the topological structure of the global complex, and modeling approaches to stitch together 
information obtained through various techniques, and has shown powerful ability in a number 
of complicated topics, including studies of notoriously difficult targets such as membrane 
proteins, [19-20] and investigations of ligand binding processes such as the report of bound 
lipids and the effects of nucleotide binding of ATPases. [21] 
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Figure 2 Selected mass spectrometry based methods for structural biology. (A) Purification of a 
protein complex by a biochemical approach. (B-C) Chemical cross-linking MS (CX-MS) workflow. (D) 
Affinity purification coupled to MS (AP-MS) workflow. (E) Native MS workflow. (F) Integration of 
diverse structural data by computational modeling. Thereby a model (or an ensemble of models) is 
searched that satisfies the structural data. [12] 
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2.3 Chemical cross-linking MS 
Chemical cross-linking MS (Figure 2 B, C) is based on the fact that in proteins or protein 
complexes, amino acid residues in spatial proximity (20-30 Å) can be physically connected 
by covalent bonds via a cross-linking reagent. Target proteins or protein complexes are 
chemically cross-linked in solution under near-physiological conditions, enzymatically 
hydrolyzed to peptides, and the resulting peptides are analyzed by mass spectrometry. The 
cross-linkers can be either cleavable, so that the linked peptides are uncoupled before or 
during the mass spectrometric fragmentation process, or in more common cases non-
cleavable, where ions of the cross-linked peptides are fragmented as single chemical entities. 
[12, 22] Various analytical enrichment strategies have been developed to increase the 
detectability of the cross-linked peptides in the complex peptide mixture, which is crucial to 
the efficiency of the technique because both the amount and the number of cross-linked 
peptides are vastly lower as compared to the abundance and number of non c ross-linked 
peptides, and facilitate the latter data processing steps to the MS data. [23-25] With the help 
of these efforts, successful applications of CX-MS integrated with other techniques to 
challenging large macromolecular assemblies have been reported: recent examples include 
the determination of the architecture of the 2.5-MDa 26S proteasome using CX-MS together 
with cryo-electron microscopy (EM) and X-ray crystallography [26], and the deciphering the 
subunit topology of the TRiC/CCT chaperonin using CX-MS combined with molecular 
modeling. [27-28] 
2.4 Labeling techniques 
The local structures of the proteins are studied conventionally by X-ray crystallography and 
NMR. Yet different labeling techniques combined with MS measurement provide alterative 
pathway towards the structural information as well as the changes and dynamics of protein 
structures. Hydroxyl radical labeling uses the hydroxyl radicals (•OH) to induce covalent 
modifications at solvent-exposed amino acid side chains, which is detected as a +16 Da mass 
shift. The difference in the reactivity of individual side chains, keeping notion that it varies 
according to their chemical nature, reflects the solvent accessibility of their specific location. 
[29-32] The HDX technique, on t he other hand, probes the protein structure with the 
information of the backbone amide hydrogens. The details of this technique will be discussed 
in the later part of this chapter. 
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2.5 Perspectives of combining the structural MS strategies 
Increasing attention has been paid to the combination of the above approaches as each of 
them has unique strengths and weaknesses. AP-MS is able to detect subtle changes in 
interaction partners and dynamics and is as well able to deal with lowly expressed complexes. 
MS of intact assemblies is able to assess the absolute stoichiometry of the intact complex and 
multiple subcomplexes, yet both of them lack the ability to provide finer structural details on 
the amino acid or pseudo-amino acid scale resolution. On the other hand, CX-MS provides 
peptide resolution on t he interaction site of two subunits, and HDX-MS (which will be 
presented in the next section) reveals protein conformations and dynamics in seconds to 
hours time scale and down to single-amide resolution, but both methods cannot probe the 
overall stoichiometry or higher oligomeric state. Therefore it is believed that these 
approaches are complementary and their combination could generate complete interaction 
maps on global protein assemblies (Figure 2 F), and furthermore, enable subsequent merging 
of such datasets with topological information from IM-MS and cryo-EM results. [12, 15, 17] 
3 Hydrogen/deuterium exchange  
Protein molecules contain a huge amount of hydrogen atoms. Part of these hydrogen atoms 
are bound to carbon atoms through stable covalent bonding. Whereas other hydrogen atoms, 
those in O–H, N–H, and S–H groups, are labile due to the higher eletronegativities of the 
binding atoms, and they can exchange with the surrounding water. HDX targets all labile 
hydrogen atoms.  
3.1 Brief history of HDX studies 
The study of protein hydrogen exchange dates back to the pioneering work of Linderstrøm-
Lang and his coworkers at the Carlsberg Laboratories in Copenhagen in the 1950s. [33-34] 
Although a lot of the early data from these days were incorrect, Linderstrøm-Lang inferred 
the basic dynamic mechanisms of the hydrogen exchange processes and suggested the 
equations that govern measurable HDX, which are still accepted today. 
The extraordinary potential that hydrogen exchange offers was, however, challenged for a 
long time by the difficulty of accurately measuring the incorporated deuterium. The 
development of multidimensional NMR methods first provided an efficient way to measure 
HX in rather small protein molecules on single amide level, as the amide proton peaks (from 
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hydrogen) disappear after deuteration because 2H has a spin of 1and 1H has a spin of ½. [34-
36].  
Alternatively, due to the mass shift from 1.0078 Da of 1H to 2.0141 Da of 2H, the exchange 
of deuterium can be measured by mass spectrometry. In 1991, Katta and Chait reported the 
first application of MS-based HDX [37], where they probed different conformers of ubiquitin 
by HDX-ESI-MS. The first HDX MS experiments to include protease (pepsin) digestion and 
HPLC separation were reported 1993. [38] In this work, exchange reaction was quenched at 
different time points by acidification and temperature decrease, followed by pepsin 
proteolysis, HPLC separation and FAB-MS analysis. This prototype develops into the 
standard bottom-up approach without major changes in the basic experimental design, but it 
becomes increasingly powerful thanks to the vast advances of instrumentation and software. 
The development of fragmentation methods, electron capture dissociation (ECD) [39] and 
electron transfer dissociation (ETD) [40], leads to the alternative top-down approach.  
3.2 General principle of hydrogen exchange 
3.2.1 The exchange of free-exposed hydrogens 
The mechanism of such reaction has been studies ever since the first reports of the HDX 
method. [33, 41-43] Starting from the fundamental of the proton transfer reaction, now the 
widely accepted pathway can be described in three steps (Equation 1): formation of a 
hydrogen-bonded complex via diffusional collisions between a proton donor (X-H) and an 
acceptor (Y); rapid equilibrium redistribution of the proton between the proton donor and 
acceptor within the complex, and dissociation of the hydrogen-bonded complex. [42] 
X H + Y [
k1
k-1
X H Y X H Y] X+Y H
k2
k-2
k3
k-3                                    (1) 
k = k1( 10𝛥𝑝𝐾1+10𝛥𝑝𝐾)                                                                                               (2) 
The overall rate constant can be approximated as Equation 2, where ΔpK represents the 
difference between the pK value of the proton acceptor and donor. [44-45] Therefore, if the 
acceptor is a much weaker acid than the donor, i.e. pKacceptor ≫ pKdonor, the rate constant (k) of 
the proton transfer will be equal to that of the diffusional collision k1, meaning that every 
collision between X-H and Y leads to a successful transfer. On the contrary, if the transfer 
proceeds from a weaker to a stronger acid, the transfer will be much slower than the diffusion.  
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This explains the different behavior of the hydrogen atoms in different groups in proteins and 
allows delineating three groups of hydrogen atoms. (1) Hydrogens bonded to carbon show a 
very high pKa and thus these hydrogens hardly exchange with surrounding hydrogens. (2) 
Hydrogens bonded to heteroatoms of -N, -O and -S on polar side chains or the N/C termini 
display much a lower pKa values for deprotonation (lower than 13 at pH 7, 25 °C) than the 
pKa (15.7 at pH 7, 25 °C) for OH- protonation, and therefore they are easily exchanged with 
OH-. (3) Hydrogens at backbone amide groups, however, has a much higher pK value (~18), 
in other words, the exchange of such hydrogens proceeds from a weaker to a stronger acid, 
and thus is much slower. This explains why the hydrogen exchange that is most often 
measured in proteins is that of the backbone amide hydrogen (NH).  
(a) Base catalysis 
 
(b) Acid catalysis
 
Figure 3 mechanisms of hydrogen/deuterium exchange in peptide/protein backbone amides. 
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The H/D exchange on peptide/protein backbone amide groups may proceed via base- or acid-
catalyzed mechanisms. [46-47] The base-catalyzed pathway, first proposed by Berger et al. in 
1959, has been quickly accepted without much debate. Exchange begins from abstraction of 
the amide proton by a hydroxide ion and the formation of an imidate anion, which is 
subsequently re-protonated to complete the transfer (Figure 3 (a)). This is the more important 
mechanism for the physiological conditions in which proteins exist, yet it is also possible that 
the exchange happens via the acid-catalyzed pathway. The latter, however, has gone through 
a long way of discussions between two distinct mechanisms. [46, 48-49] Nowadays the more 
commonly accepted pathway is the so-called O-protonation (Figure 3 (b)): the protonation of 
the carbonyl oxygen happens first, lowering the pK for deprotonation of the amide group. The 
amide hydrogen is therefore removed by a water molecule to produce the imidic acid 
intermediate that extracts a d euterium and returns to an amide. This mechanism is more 
reasonable due to the fact that on the backbone amide, the more basic group is the oxygen 
rather than the nitrogen. Whereas an earlier-raised pathway, N-protonation (Figure 3 (c)), 
starts directly from the protonation of the amide nitrogen. This mechanism is mostly inhibited 
but still not strictly impossible. In sum, the base-catalyzed exchange occurs via the imidate 
anion, and is related to the structural information of the amide nitrogen. The acid-catalyzed 
exchange, on the other hand, is predominantly occurring via O-protonation pathway and is 
influenced by the amide carbonyl. Thus exchange rate constant of freely exposed backbone 
amide hydrogens can expressed as: 
kex = kacid[D3O
+] + kbase[OD
-]+ kwater                                                 (3) 
According to reference studies using small peptides [33, 48, 50], at low salt conditions and 
20 °C kbase can be as much as eight orders larger than kacid and eleven orders larger than kwater. 
This implies that the base-catalyzed exchange is predominant at physiological conditions.  
Plotting log(kex) versus pH leads to a V-shaped curve (Figure 4), with a minimum exchange 
rate at pH 2.5 - 3.0. This can be deduced by differentiating Equation 3 as 
+ + 2
3 3[D O ] [D O ]
ex w
acid base
k K
k k
∂
= −
∂                                                 (4) 
and setting to zero, where Kw represents the ionization constant of water. On either side of the 
minimum pH, the slope of Δlog(kex)/ΔpH is approximately equal to 1 for higher pH and to -1 
for lower pH, indicating a close to first-order pH dependence of kex. This reflects that each 
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kcl 
shift of one pH unit from the pHmin changes the exchange rate by 10-fold, and that the 
exchange is nearly four orders slower at pH 2.5 than at pH 7.  
 
Figure 4 Dependency of the exchange rate kex
51
 on solution pH for amide hydrogens within a 
polyalanine peptide. [ ] 
Another feature that affects significantly the exchange rate is the temperature. At fixed pH, 
reducing the temperature alters the concentration of OD- through modification of the Kw. In 
addition, the diffusional collision rate k1 also changes in accordance to temperature. The 
exchange rate reduces approximately one order of magnitude when the temperature lowers 
from 20 to 0 °C. 
3.2.2 The exchange of amide hydrogen 
In native (folded) proteins, a few hydrogen atoms are fully solvent-accessible that can readily 
exchange at a fast and often similar rate. In contrast, some of the NHs exchange quickly and 
others exchange much more slowly with half-lives up t o months. [9, 41, 45, 52-54] This 
difference in the exchange rate can be demonstrated through the following kinetic model: 
NH (protected) 
𝑘𝑜𝑝
�� NH (unprotected) 
𝑘𝑒𝑥
��ND (unprotected) 𝑘𝑜𝑝�� ND (protected)              (5) 
where kop and kcl are the rate constants for the unfolding (opening) and refolding (closing) 
events that expose amide hydrogen to the solvent. This assumes that amide hydrogen requite 
to be in a open state in order to exchange with the surrounding water. Although there is also 
experimental evidences that the exchange reaction can occur when the protein is folded [55-
56], most studies have been based on the above model and assume that the exchange-
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competent state for an amide hydrogen is either a fully or partially unfolded state. In these 
conditions, the overall exchange rate constant kHDX is deduced as: 
op
HDX ex
cl ex
k
k k
k k
=
+
                                                               (6) 
Two extreme regimes have typically been demonstrated: ordinarily proteins are stable in their 
native state so the refolding process is much faster than the exchange, kcl ≫ kex, and the kHDX 
is therefore approximated as: 
kHDX  = Kopkex                                                                      (7) 
where Kop = (kop/kcl) is the equilibrium constant of the unfolding process, implying the 
probability of the exchange reaction occurring in a single unfolding event. This regime is 
referred to as EX2, which is more prevalent in physiological conditions than the other regime, 
EX1. The latter refers to the case when kex ≫ kcl, meaning that the unfolding event is rate 
limiting, i.e.  
kHDX = kop                                                                       (8) 
The EX1 exchange is often observed under protein denaturing conditions or by increasing the 
intrinsic exchange rate. The two kinetics are easily distinguishable by mass spectrometry [57]: 
EX1 regime gives rise to two distinct and separated mass envelope (the undeuterated and 
deuterated forms) while EX2 regime gives a gradual shift of the mass envelope with time. 
An example of the EX1 and EX2 scheme is given in Figure 5, from a work on l ipid 
dependent changes of the membrane scaffold protein MSP1D1. [58] The HDX of the lipid-
associated states (Figure 5, spectra on the right and red plots) shows a typical EX2 pattern, i.e. 
a single isotopic distribution. In the HDX of the lipid-free form, the peptide displays EX1 
kinetics which can be distinguished by the presence of two isotopic distributions, e.g. in the 
spectrum of 5m. For the peptide with EX1 unfolding, each time point is fitted with two 
Gaussian distributions. The center of these distributions is used to plot the deuterium uptake 
for both the low (solid line, filled symbols) and high (dashed line, empty symbols) mass 
populations as shown in blue in Figure 5. 
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 Figure 5 Mass spectra and deuterium uptake plots for peptide MSP1D1(72-82) in both the lipid-free 
(blue) and lipid-associated (red) states.[58] 
 
3.3 Incorporation of deuterons: labeling strategies  
Exposing a protein to a D2O-containing environment leads to H-D replacements that increase 
the mass of the protein by one unit per exchange event, this is referred to as an ‘‘exchange-in’’ 
scenario, which will be mostly used throughout this thesis. Although less commonly used, it 
is also possible to conduct measurements in an ‘‘exchange-out’’ protocol. In the latter case 
the protein is first fully deuterated before placing it in H2O, so that labeling occurs in the D-H 
direction. [54, 59] The protocols to induce the deuterium incorporation into the protein can be 
generally grouped into two types: continuous labeling and pulse labeling. 
3.3.1 Continuous labeling 
In the continuous labeling strategy (Figure 6), the exchange is initiated by placing the 
unlabeled protein into a D2O-based solvent system (e.g., by a rapid dilution of 15-20 fold). 
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The final deuterium concentration after the dilution exceeds 95%, so that the exchange 
reaction is forced in only one direction, H→D. Unstructured and highly dynamic protein 
segments undergo fast exchange (blue and red colors represent protons and deuterons, 
respectively), while less dynamic segments exchange more slowly (Equations 5-8). At 
various time points from minutes to hours, aliquots are removed from the deuteration solution, 
and the exchange is quenched by rapid acidification.  
 
Figure 6 Schematic representation of typical continuous labeling work flow. [60] 
The nature of the protein properties that are being monitored with continuous labeling has 
gone through different debates. It has always been demonstrated that HDX provides direct 
information on t he solvent accessibility of amide groups. [52, 61-62] Yet according to 
detailed studies of the exchange patterns [54, 63], it s eems more appropriate to state that 
HDX rates reflect the intactness of the hydrogen bonding network, i.e. solvent exposure and 
breakage of hydrogen bonds are both required for the exchange to occur, which should be 
met simultaneously in the “unprotected” conformation in Equation 5. It is also claimed that 
that HDX primarily reports on the stability and dynamics of secondary structure elements, 
because most intramolecular hydrogen bonds are associated with α-helices and β-sheets. [54, 
64] 
3.3.2 Pulse labeling 
Pulse labeling strategy, although less commonly used, brings unique type of information: it 
detects and characterizes protein folding intermediates, short-lived species that exhibit 
structural features in-between the native and the unfolded states. [58, 65-66] In these studies 
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(Figure 7) an initially denatured protein is rapidly transferred to a suitable solvent 
environment, thereby triggering the refolding process. Subsequently, the protein is exposed to 
a brief (millisecond to several seconds) HDX pulse at a well defined time point during the 
reaction. A series of measurements is conducted by varying the time interval between folding 
trigger and pulse. In this way it is possible to obtain detailed insights into the temporal 
sequence of events that lead from the unfolded state to the native conformation. Pulsed HDX 
is typically handled under basic conditions (pD 8–10) to ensure that extensive isotope 
exchange can occur during the short labeling step, taking advantage of the pD-tunability of 
kex according to Equation 3. The labeling pulse may be quenched by rapid acidification to pH 
2.5 or solvent evaporation during ESI in the case of on-line HDX-MS approaches. Often the 
folding intermediates contain regions that are hydrogen bonded to some extent, whereas other 
segments remain disordered. When the pulse conditions are well-controlled, the free amides 
become completely deuterated, whereas those that are even marginally protected remain in 
their N–H form. The ‘‘all-or-nothing’’ (protected or not) readout under such conditions 
allows folded and unfolded regions to be readily differentiated.  
 
Figure 7 Example of typical pulsed HDX work flow. [67] Mixing of acid-denatured protein with 
ammonium hydroxide triggers refolding at mixer M1 in a H 2O environment. After a variable folding 
time (tfold, ranging between 10 ms and 1 s), addition of D2O at mixer M2 initiates a 20 ms labeling 
pulse. HDX is quenched by formic acid solution after M3 for 1 s, before the solution is infused into the 
ESI source of a mass spectrometer. pH-meter readings for D2
3.4 Measuring the HDX 
O-containing solutions are referred to 
as pH*.  
Any method that is sensitive to the properties of the isotopes of hydrogen can be used to 
monitor the HD exchange. The prior applications were the measurements of increasing 
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radioactivity of the labeled proteins after incorporation of tritium (T2O) [44], and later NMR 
was introduced because deuterium is NMR silent and replacement of amide hydrogens by 
deuterons causes the disappearance of the corresponding 1H NMR peaks. [68] The first report 
of protein HDX-MS appeared in 1991[37], thanks to the application of ESI.  
Mass analyses of deuterated proteins can be conducted at the global protein level, which 
represent a straightforward approach for characterizing global changes in protein structure 
and stability, either when the protein is alone to monitor natural motions under equilibrium 
conditions or in response to ligand binding, complex formation, activation, presence of 
denaturants, etc.  
To achieve spatial resolution, the deuterium levels of short peptide fragments have to be 
measured. This is achieved, before the mass measurement, either by proteolysis of the 
deuterated protein, or by fragmentation of the protein in gas-phase with ECD or ETD, 
referred to as the bottom-up and top-down approach, respectively (Figure 8). 
 
Figure 8 Brief illustration of the difference between bottom-up and top-down HDX-MS protocols. [54] 
In bottom-up experiments the protein is subjected to limited proteolysis after labeling. Each protein 
molecule is cleaved multiple times, generating solution-phase peptides. Top-down experiments 
involve the dissociation of intact proteins in the gas phase. Individual protein molecules usually 
experience only one cleavage event, resulting in complementary N- and C-terminal ion-pairs (c/z-ions 
in the case of ECD and ETD). 
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3.4.1 Bottom-up approach 
The classical proteolysis/LC-MS approach, or the bottom-up approach of HDX-MS, was first 
reported in 1993. [38] It was originally developed as an extension of the NMR and 
radioactivity strategies, yet through the past decades this approach has been gradually 
improved thanks to the great instrumental improvements of the chromatography and mass 
spectrometry as well as the variations of the experimental protocols. Typically, continuous-
labeling HD exchange is followed by acid quenching. [54] Subsequently, an acid-tolerant 
protease such as pepsin is added to induce limited proteolysis. The resulting peptides are 
desalted and separated by reversed phase LC, and analyzed by ESI-MS. The solution 
temperature is lowered to ~0 °C during quenching and all subsequent steps, and proteolysis 
and LC separation are conducted in a minimum of time (~30 min. or less), in order to 
minimize the back-exchange effect that some deuterons incorporated in backbone amides 
exchange back with surrounding hydrogen. In this process, no information is obtainable for 
side chains due to their very high back exchange rates.  
3.4.1.1 Back exchange 
It is critical for HDX-MS to retain the label as much as possible during the experimental 
process. However, as stated above, after deuteration the proteins have to undergo proteolysis, 
desalting, concentration, separation and mass measurement, all of which are carried out in 
protiated solution. Therefore, deuterated positions on a mide groups as well as side chains 
may all revert to hydrogen. These back-exchange processes cannot be completely avoided. 
On the side-chains, due to the high kex value, all deuterons are back-exchanged to hydrogen. 
On the amide backbones, contrarily, the back-exchange can be minimized if careful control is 
taken during the experiment. 
Primarily, a pH at which exchange is at the minimum state and a t emperature as low as 
possible are maintained during the whole procedure after the HD exchange. According to 
Equations 3 a nd 4, t he exchange rate reaches the minimum at pH ~ 2.5, whereas the 
quenching temperature is usually set 0-4 °C, the temperature limit a t which the LC 
experiment may be carried out. Comparing to the condition at pH 7 and 25 °C, the exchange 
rate constant of the unprotected hydrogen/deuteron is five orders of magnitude lower in this 
quenching condition. The half-life for back-exchange, depending on t he sequence of the 
proteins and proteolyzed peptides, varies from 30 to 120 min [45, 50-51], and therefore the 
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whole analysis process after the exchange reaction has to be completed as quickly as possible. 
It has been proven that if proteolysis and separation steps are kept under 12-15 min total, 
deuterium recovery can be as much as 85%, while the losses in the ESI interface during 
spraying can be kept to less than 5%. [66] Notably, although the measured increases in mass 
correspond predominantly to the exchange on the backbone amides, rich content of arginines 
can complicate the analysis because arginine has a side chain amide hydrogen with a 
minimum exchange rate close to that of the backbone NHs, so that the deuterons on these 
groups may not be completely washed away before the mass analysis. 
Various methods have been reported to adjust or reduce the back-exchange. For example, the 
deuteration level can be corrected by compensating the extent of labeling loss for completely 
deuterated proteins. [38] The use of supercritical fluid chromatography (SFC) is also 
introduced as an alternative to HPLC, taking advantage of separating the peptides using CO2 
rather than protiated solvents as mobile phase, which partly reduces the possibility of back-
exchange although the proteolysis step cannot be accomplished in supercritical CO2. [69]  
3.4.1.2 Choice of protease 
The quenching condition, i.e. pH 2.5 and ~0 °C has to be maintained strictly during the whole 
analytical process. The protease to hydrolyse the proteins, therefore, has to be active at this 
chosen pH and temperature. Pepsin has always been the enzyme of choice. [38, 51] Pepsin is 
most active at pH 1.5-2.0. [70] Its optimal temperature is 37-42 °C, but is still active at 0 °C. 
Unlike trypsin and other strictly specific enzymes, pepsin shows only a preference of 
cleavage towards some amino acid residues. The weak specificity of pepsin results in both 
advantages and hindrances for the HDX MS methodology. The peptic peptides detected by 
mass spectrometry can achieve sequence coverage of 100% or higher, i.e. overlaps of peptide 
fragments are frequently observed. However, the identification of peptides from such a 
complicated mixture is not straightforward via cleavage position alone. Therefore, tandem 
mass spectrometry (MS/MS) has been considered as an indispensable step for the peptic 
peptide identification.  
However, incomplete cleavage of large proteins and limited number of peptic peptides 
sometimes restrict the range of applicability when using pepsin alone. Additional proteases 
(protease type XIII from Aspergillus saitoi and protease type XVIII from Rhizhopus) were 
introduced in the HDX MS method, and have been demonstrated to increase the sequence 
coverage of the peptide mixture. [65, 71-72] These proteases are, similarly as pepsin, not 
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specific in the cleavage site, but they are not as efficient as pepsin under quench conditions. 
Yet combining the different proteases yields significantly higher sequence coverage and 
better spatial resolution as they each have slight preferences of the cleavage sites.  
3.4.1.3 Chromatography 
Typically, for a protein of about 50 kDa, more than one hundred peptides are generated after 
pepsin hydrolysis. [57] In addition, the peptide mixture is usually in a salt solution which 
cannot be directly analyzed by MS. Thus prior to mass analysis, the peptides are desalted and 
separated using HPLC to minimize mass overlap and ion suppression in the mass 
spectrometer. The length in time of the HPLC run and the detailed gradient needs to be 
appropriately designed, so that the loss of deuterium through back exchange with solvent is 
minimized, while the resolution can be achieved as high as possible. As stated above, 85% of 
the total exchange can be retained if the proteolysis and separating steps are finished within 
15 min. IN order to compensate the loss of labeling and the gain in final sequence coverage, a 
30-40-min time scale for proteolysis and separation is typically applied nowadays.  
The complexity of the samples that can be analyzed in such a f ast gradient is generally 
limited comparing to standard LC separation gradient that sometimes last up to several hours, 
especially when using slower scanning or lower-resolution mass spectrometers. In addition, 
the short time allocated to the separation makes it d ifficult to implement capillary 
chromatographic systems that have typically higher elution delays due to larger relative in 
system dead volumes. [73] Therefore different approaches have been reported to improve the 
LC efficiency and reduce the back-exchange during the chromatography.  
Besides the above-mentioned use of SFC, the replacement of H2O in the aqueous mobile 
phase with mixed solvent of H2O and polar aprotic modifiers [dimethylformamide (DMF) or 
N-methylpyrrolidone (NMP)] during the HPLC step [74] was another option to decrease the 
back-exchange derived from the idea of avoid the use of protiated solvents.  
Other strategies involve the decrease of the temperature below zero point. The half time of 
back-exchange extends to 18 hour s at -30 °C. [73] To achieve successful LC at subzero 
conditions, buffer modifiers need to be carefully selected that can reduce the freezing point of 
commonly used aqueous solvent systems, are mass spectrometry compatible, and do not  
preclude the use of liquid chromatography. Once such a system is well designed, it allows 
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much longer time to perform extensive chromatographic separation or subsequent sample 
processing.  
As discussed in 2.4, ion mobility separation (IMS) has been widely applied to the analysis of 
proteins after ESI and MALDI. Based on the drift behaviors through an inert gas under the 
influence of an electric field, ions are separated due to the differences in the sizes, shapes and 
charges. These features are different from that of reversed-phase (RP)-HPLC in bottom-up 
HDX-MS workflow, thereby making IMS independent to HPLC and adding an additional 
dimension of separation. [75-76] Commercial IMMS instrument uses IM to separate ions 
between the ion source and mass analyzer, which occurs on a millisecond timescale; many 
mobility separations can occur during each chromatographic peak (which are typically on 
more of a seconds timescale). It is also proven from a demonstrative study of a small protein 
[75] that no additional losses of deuterium were created during the IMS process, and the drift 
time does not change upon solution-based deuterium incorporation, thus the addition of IMS 
increases the LC peak capacity of the experiment and should aid in HDX studies of very large 
proteins and protein complexes.  
3.4.2 Top-down approach 
Unlike the proteolysis/LC-MS approach that cleaves the deuterated proteins before 
introducing them into the mass spectrometer, in the “top-down” approach, fragmentation of 
the proteins takes place in the gas phase. Every individual chain typically experiences only a 
single cleavage event, resulting in a complementary N- and C-terminal ion pair. Spatial 
resolution can be obtained in top-down experiments because not every protein is cleaved at 
the same backbone site, such that a ladder of ion pairs is produced (Figure 8, lower part). 
Early attempts to apply top-down strategies in HDX/MS were based on the use of collision-
induced dissociation (CID). Yet the collisional heating of CID leads to a “scrambling” 
process, the intramolecular migration of hydrogen upon activation and can completely 
randomize the H/D exchange pattern that was imprinted onto the protein backbone during 
solution-phase HDX. The uses of ECD [39] and ETD [40] have basically solved the 
scrambling problem. Both techniques involve the transfer of a low energy electron to a gas-
phase protein cation, generating the c/z- ion pairs. And the low energy induced in such 
fragmentations is critical as scrambling is negligible during the process, provided that 
collisional activation in the ion sampling interface is kept at a minimum. Potential advantages 
of these electron-based fragmentation techniques include an improved spatial resolution and 
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the opportunity to minimize back exchange. [62] Both ECD and ETD have claimed high 
sequence coverage, allowing enhanced spatial resolution to be achieved, in some cases even 
down to the single amide level. [67] As chromatography is no longer a limit for the solvent 
selection and the analysis can be much faster because the proteolysis and separation steps are 
replaced by the gas-phase fragmentation, more flexible strategies can be applied to reduce the 
back-exchange. The temperature in the quenching condition can be subzero, e.g. Amen et al. 
[77] have reported a chip-based nanoelectrospray approach based on cooling to subzero 
temperature    (-15 °C), offering additional advantages over nanoelectrospray needles such as 
high spray reproducibility and spray stability and the possibility for automation [78], and the 
deuteration level remains ~95% after 10 m in of back-exchange. Yet when the protein size 
increases, i.e. when the protein is larger than 30 kDa, the top-down approach has not 
conquered the limitation of incomplete sequence coverage, which is a hindrance from the gas 
phase fragmentation efficiency. [79] Combining the bottom-up and top-down approach is 
therefore another option to take advantages of both methods, which is going to be discussed 
later.  
3.4.3 Mass measurement and data processing 
Relative HDX levels of individual protein fragments are determined as a function of 
deuteration time t according to  
deuteration level (t) = 
𝑚(𝑡)− 𝑚0
𝑚𝑚𝑎𝑥 −𝑚0                                              (9) 
where m(t) is the centroid mass of the peptide of interest, whereas mmax and m0 are the 
corresponding reference masses for completely labeled and unlabeled peptide, respectively. 
Each amino acid residues in the protein corresponds to a unique kinetic, yet this single site 
resolution are difficult to achieve with common experimental condition. Therefore the 
exchange rate constants on the peptide level are always determined rather than the single 
amide group, as: 
deuteration level (t) = A0 + A1(1 – exp[-k1t]) + A2(1 – exp[-k2t])            (10) 
where A0 is the fraction of amide sites that undergo burst phase exchange, and A1, A2 are the 
fractions that are labeled with average rate constants k1 and k2, respectively. [54] In many 
cases, a single exponential term is sufficient for the fitting of the observed kinetics, and it is 
not very common to observe kinetics that requires more than two exponentials. 
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3.5 Application of HDX-MS in protein structural studies 
3.5.1 Protein folding 
HDX-MS is powerful in the study of protein folding mechanisms. This arises from the nature 
of the exchange reaction: transient intermediates in a folding pathway will exhibit different 
exchange rate constants according to their conformation, especially in the EX1 regime. [9] 
Thus different protein populations become labeled to different degrees and are separated in 
the masses, and the respective exchange rates can be measured. 
Such topics are usually studied using the pulse-labeling strategy, as described in xx. The mass 
of the labeled proteins can be measured directly with MS, which provides global information 
on folding process. Recently researches have been carried out on the more detailed level of 
the different conformers, by analyzing the different deuteration level on protein fragments 
either by bottom-up or top-down approaches. For example, Pan et al. reported a study of 
structural characterizing of an apo-myoglobin (aMb) kinetic folding intermediate with pulsed 
top-down HDX. [67] 
 
Figure 9 Deuteration level D of backbone amides for the apo-myoglobin (aMb) folding intermediate 
(top, refolding time tfold = 10 ms), and for the native control (bottom, tfold
67
 = 1 h) after pulsed HDX. 
The data were obtained by top-down ECD. Open and f illed symbols represent deuteration levels 
deducted from c and z- ion data, respectively. Also shown is the α-helical secondary structure of 
native aMb. Helices are denoted as A–E, G, and H. On the right hand side of this figure the D values 
are mapped to the crystal structure of holo-myoglobin, using the following color scheme: blue, D < 
0.33; green, 0.33 < D > 0.66; red D > 0.66. [ ] 
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The work flow is demonstrated in Figure 9. Top-down ECD fragmentation of electrosprayed 
aMb allowed mass shifts to be determined for 36 c- and 34 z -ions that covered the entire 
protein sequence (Figure 9). Since deuteration level D = 1 corresponds to amides that are 
unprotected whereas fully protected sites are characterized by D = 0, it can be revealed that 
the aMb folding intermediate (Figure 9, top) remains mostly unprotected throughout the first 
105 residues, marginal protection is seen only for helix A and only helices G and H are well 
developed at this time point. The deuteration behavior in folded conformer (Figure 9, bottom), 
on the other hand, shows that completely deuterated regions and virtually unlabeled regions 
are well-correlated with the the secondary structure of native aMb, i.e. the loop regions in the 
native protein are heavily deuterated, whereas helices are mostly protected. The partial 
protection observed in the C–D loop is consistent with hydrogen bonding data obtained by 
crystallography. These results reveal that the initial step of aMb folding involves formation of 
helices G and H. An additional marginal stabilization of helix A seems likely. Formation of 
the remaining helices B, C, D, and E occurs at a later stage. 
3.5.2 Protein interactions  
Equally important, HDX-MS has been applied in the studies of protein interactions. Upon 
interaction with metal ions, ligands, other proteins or large biomolecules, the amide 
hydrogens at the binding interface may be protected from exchange. Therefore a decrease in 
the deuteration level should be observed. Such a behavior is used to identify the binding sites 
of the above situations by comparing the deuteration level and the exchange kinetics of the 
non-complexed proteins with those of the complexed ones.  
The change in the deuteration level upon complex formation, however, does not only involve 
the direct binding site, which is a precaution that should be carefully taken in the studies of 
protein interactions, especially in the case of small molecules. The alterations of the 
deuteration behavior can be caused by the protection of the binding agents, or in many cases, 
by the change in the unfolding/refolding motion, which can happen in regions far from the 
binding sites. In addition, not all binding regions may be probed under the standard HDX-MS 
condition, e.g. information of interactions involving the side chains can be lost. 
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Figure 10 Top: Relative deuterium uptakes for peptic peptides from N- to C-terminus of FMO after 10 
min of exchange. Peptide regions showing significant differences in deuterium uptake (>5% 
difference) in the presence of CsmA are labeled in red font and marked with red stars. Bottom: FMO 
monomer structure mapping with the deuterium uptake patterns. Peptide regions of FMO undergoing 
significant deuterium uptake differences between apo and holo states are in red. Peptide 233−239 
located in the center of the trimer underwent low deuterium uptake (blue), whereas peptide 2−17 
located on the outer shell of the protein underwent relatively extensive deuterium uptake (black). [80]  
Nonetheless, when the deuteration behavior is carefully interpreted, it can be powerful to 
resolve the binding site and conformation changes, especially when coupling with 
computational modeling and docking studies. A recent work by the Gross group represents a 
delicate illustration of typical bottom-up HDX-MS strategy to resolve the interaction question. 
[80] In this work, the binding interface of the FMO antenna protein and the CsmA baseplate 
protein was revealed: global exchange kinetics were first compared for FMO and 
FMO+CsmA without proteolysis, showing clear decrease in the deuteration level upon CsmA 
binding. Then the proteins were proteolyzed by pepsin after a 10-min deuteration, and 
deuterated peptides were analyzed that generate information on the binding sites on FMO. 
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Sequence coverage of ~80% was achieved, and peptides consisting of 123−129, 140−149, 
150−162, 191−208, and 224−232 showed significant decreases of deuteration levels after 
CsmA binding (Figure 10, top). All of these sites were located on one side of the FMO 
protein when they were mapped on the previously generated X-ray crystal structure, which is 
referred to as the Bchl a #1 side of the protein (Figure 10, bottom). The results indicated that 
the CsmA protein interacts with the Bchl a #1 side of the FMO protein, and were coincident 
with results from a previous study [81] on the membrane orientation of FMO in green-sulfur 
bacteria showing the Bchl a #1 side of the FMO interacts with the chlorosome. 
3.5.3 Aid in structure elucidation and crystal production 
As a major tool to determine protein structure, crystallography always meets the obstacles of 
successfully obtaining the protein crystals due to unstructured regions in some proteins. HDX 
MS can provide valuable information to precisely locate the disordered regions. After a brief 
D2O pulse, unstructured regions are intensively deuterated and can be probed by MS, 
whereas folded regions stay with low deuteration level.   
3.5.4 Quality control 
A less commonly mentioned domain where HDX MS may be used is the quality control of 
protein folding. As the different folding behavior controls the deuteration behavior that can 
be monitored either by continuous-labeling or pulse-labeling HDX, by comparing the 
deuteration level of certain regions in the native conformer and refolded conformer, one can 
investigate various factors regarding the protein folding, e.g. the effects of mutations on 
protein structure, the correctness of the folding of a recombinant protein, the protein 
preparation protocols to produce correctly folded proteins, etc.  
3.6 The on-going improvements and perspectives for HDX-MS 
As the method of HDX-MS continues to develop as a mature tool for structural proteomics, 
the use of it has extend from small proteins (~50 kDa) to larger proteins and protein 
complexes (up to 300 kDa), and more complicated problems are subjected to be answered, 
often in combination with other structural analysis tools. Meanwhile, HDX MS has been 
questioned for the following limitations, namely the control of back-exchange, the 
reproducibility, the spatial resolution, the protein size and the consumption of time. Based on 
these issues, various approaches have been reported. 
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3.6.1 Automated experimental work-flow and data processing 
Since the first prototype of fully automated H/D exchange system was reported in 2006 [82], 
different groups have designed the automated work-flow of bottom-up HDX-MS [83-84], and 
commercial products have now become available. Such robotic systems can conduct replicate 
runs in temperature-controlled autosamplers for multiple HDX times, followed by on-line 
proteolysis using immobilized enzyme columns, LC separation, and MS analysis. [54] 
Considering the varieties that have large effects on the isotope pattern measured by the mass 
spectrometer as a result of the isotope incorporation, one will realize that the experimental 
handling during the labeling, quenching and proteolysis steps, the pH and the temperature are 
the most crucial factors, and a slight difference of these parameters leads to large error bar in 
the final measured mass. [85] This is why the automated systems are highly demanding: 
although such systems takes much longer to install, once well operated, they can help control 
the many variables and make HX MS experiments significantly easier to perform 
reproducibly. Yet the development of the robotics for HDX-MS still needs to overcome 
certain problems. For instance, as immobilized pepsin columns are commonly used in on-line 
systems, they increase digestion efficiency and limit enzyme autolysis. However, they add an 
extra element to a peptide carryover problem in the flow path. Carryover depletes deuteration 
and generates an isotopic distribution that mimics an EX1 signature in the next run. Therefore 
careful attention to system regeneration between runs is therefore required. [79] 
Automated data processing software is another topic that is intensively discussed. With only 
manually data processing, routine HX MS is generally out of reach for many, especially in an 
industrial setting. Therefore, even at present it is the processing capability rather than the 
instrumental capability that limits the protein size that HDX-MS can work with. In the past 
decade, different software platforms have been introduced for the HDX-MS data analysis. 
For example, Kan et al. reported the ExMS [85-86] platform that processes high-resolution 
MS data, verifies peptide assignment, extracts deuterium and incorporation information, and 
the checkpoints during processing allow for manual intervention in processing routines. The 
HeXicon workflow was introduced in 2010 [87] for automatic deuteration distribution 
estimation with increased sequence coverage, and it allows insight into possible bimodal 
exchange rather than just average deuteration for each time point. Waters developed their 
commercial software, DynamX, with simultaneous visualization of raw MS data, identified 
37
 
 
peptides, deuterium uptake graphs and comparability plots, and is also integrated with ion 
mobility separation. [88] 
3.6.2 Combining the bottom-up and top-down approach 
The pursuing of higher spatial resolution is critical for the competence of the HDX-MS, and 
although single amide-bond resolution has been claimed in several works to be achievable, 
such instances remain very rare. In the top-down approach, the limiting factor is usually the 
ability to transfer protein ions into the gas phase and fragment the parent ions into a sufficient 
number of product ions, especially when it comes to larger proteins above 40 kDa. [76] In the 
bottom-up approach, the spatial resolution mainly limited by the extent of peptide overlaps by 
proteolysis, which has to be performed under rather extreme conditions. Approaches aimed 
on the goal of site-specific resolution are therefore typically derived from two strategies: the 
combination of different proteases to create larger number and more overlaps of peptides as 
demonstrated in 3.4.1.2, or the incorporation of ETD or ECD into the classical bottom-up 
approach to further fragment the peptides into smaller pieces. The use of proteolysis in the 
typical bottom-up research allows large proteins in excess of 100 kDa to be analyzed 
routinely [76], whereas the use of ECD/ETD within peptide fragments generated via 
proteolysis allows sublocalizations of single amide exchange kinetics, providing that the 
instrumental conditions are carefully tuned to avoid the hydrogen scrambling. The work of 
Rand et al. [89] (Figure 11) illustrated the use of ETD fragmentation in bottom-up HDX to 
measure the exchange of individual amide linkages in the amyloidogenic protein β2-
microglobulin. A comparison of the deuterium levels of 60 individual backbone amides of β2-
microglobulin measured by HX-ETD-MS analysis to the corresponding values measured by 
NMR spectroscopy showed an excellent correlation, given that hydrogen scrambling of the 
uptaken deuterons in the gas phase was minimized as the instrumental conditions were tuned 
to ensure minimal vibrational excitation of deuterium labeled peptide ions. 
This combined approach is superior to top-down as it does not have similar limitations 
regarding protein size, and to bottom-up approach as it provides further information on 
individual sites. However, the ability to record MS/MS spectra of individual peptides that 
coelute into the mass spectrometer depends on the times required during each acquisition to 
accumulate sufficient ion statistics to accurately determine the average masses of MS/MS 
fragment ions, and this is the main hindrance for the combined approach to reach high spatial 
resolution for extremely large proteins.  
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Figure 11 Sequence coverage of β2-microglobulin obtained from peptic peptides and their ETD 
fragment ions. Peptides are shown as horizontal bars where double lines denote ETD cleavage sites 
producing abundant fragment ions suitable for measuring the deuterium levels of individual residues 
(bounded by red squares). The charge states of peptide precursor ions are indicated by plus signs, 
and secondary structure elements of β2-microglobulin are shown above the sequence. [89] 
3.6.3 High performance mass spectrometer 
As a mass spectrometry-based method, HDX-MS strongly depends on the development of the 
mass spectrometers. High performance MS instruments such as Orbitrap and FT-ICR mass 
spectrometers are equipped nowadays in many laboratories, and they provide significantly 
high resolution and high sensitivity. Higher sequence overlap is therefore achievable due to 
the increasing number of peptides that can be identified, and this is crucial to the increase of 
the structural resolution of the HDX-MS method.  
In a recent work [90], data acquired by an Orbitrap instrument and a QTOF instrument were 
compared. Three proteins with different sizes were proteolyzed by pepsin and separated by 
LC following a typical bottom-up workflow, and analyzed by the different mass 
spectrometers. The resulting MS/MS data were identified with Mascot search, giving a 
comparison of identified peptides in Table 1. Clearly both instruments result in rich data sets 
with high sequence coverage, indicating that the current state of instrumentation and data 
processing methods have generally overcome the problem of incomplete sequence coverage. 
However, on average the Orbitrap identified 64% more peptides than the QTOF, with a 42% 
overlap between the two systems, independent of protein size.  
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Table 1 Comparison of peptide identification statistics for the Orbitrap and QTOF for three different 
protein substrates. [90] 
 XRCC4 (20 kDa)  PNK (55 kDa)   α/β-TUB (110 kDa) 
 QTOF Orbitrap Overlap  QTOF Orbitrap Overlap   QTOF Orbitrap Overlap 
Counta 241 409 200  294 450 223   466 750 341 
Seq. Cov. (%) 100 100 100  97 98.1 94.5   93.3 95.8 92.1 
Redundancyb 13 19 10  7 12 5   6 9 4 
a Unique pairs of retention time and m/z. 
b Average number of times a given location is represented by a peptide. 
 
The structure elucidation of nucleotide-binding GroEL protein [91] represents an example of 
the state-of-the-art bottom-up HDX-MS with advanced instrumentation and data processing. 
GroEL is composed of 14 identical subunits of 57 kDa each (~800 kDa total), arranged in 
two homoheptameric rings stacked “back to back” to form a cylinder with a central folding 
channel for substrate proteins. The HDX experiments for apo GroEL and GroEL-ATPγS 
were optimized and automated with an autosampler interfaced with an HPLC instrument, and 
an LTQ 14.5 T  FT-ICR MS was used for data acquisition with mass resolving power of 
m/Δm50% = 100,000 at m/z 400, sufficient to resolve virtually all of the overlapped peptide 
isotopic distributions in such experiments. After data processing, more than 500 peptides 
were identified for both apo GroEL and GroEL-ATPγS. 134 were selected for data analysis 
which provided ~99% sequence coverage, including the C-terminus unstructured region and 
ensured access to structural changes throughout the protein assembly.  
The overall enhanced solvent accessibility and/or structure flexibility were also observed 
upon ATPγS binding, as indicated by higher deuteration levels throughout the sequence. For 
some of the peptides, the bimodal isotopic distributions were observed, and this could be 
ascribed to structural asymmetry between the two heptameric rings caused by ATP binding to 
one ring, which was coincident with previous cryo-EM studies. [92] Down to more details, 
upon ATP binding, significant weakening of the interactions between the GroEL subunits 
within one ring as well as between the two GroEL rings was simultaneously observed: in 
Figure 12, several interaction regions showed higher deuteration level in GroEL-ATPγS. 
Notably, such interpretations were also revealed by cryo-EM study [92] but within domain or 
sub-domain level resolution, while the HDX-MS results pinpoint the detailed sequence 
composition for such conformational changes.  
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Figure 12 The equatorial domains in three interacting GroEL subunits. Five regions (I-V) from the 
HDX comparison of GroEL- ATPγS vs. apo GroEL are colored as the color coding at bottom right. 
Two subunits in the top GroEL ring and one in the bottom yring are chosen to represent the inter-
subunit and inter-ring interactions (viewed from the outside of the cylinder). Representative peptides 
for the regions are shown in the inset table. [91] 
 
4 HDX vs. other structural tools 
Conventional biophysical tools used for protein structural studies include spectroscopic and 
chromatographic methods, X-ray crystallography, NMR, small angle X-ray scattering 
(SAXS), cryo-EM, etc. [54, 93] Optical spectroscopy and chromatographic methods are often 
employed for interrogating global structural aspects. X-Ray crystallography remains the gold 
standard for obtaining atomically-resolved conformational information on na tive proteins. 
NMR techniques provide single-proton level resolution and can be applied to partially 
unfolded proteins.  
The HDX-MS method has proven itself a powerful complement or even alternative to these 
traditional tools. Unlike X-ray crystallography, HDX-MS is carried out in solution phase and 
gas phase, and therefore crystallization is not required. It can reveal changes to conformation 
and dynamics on a wide timescale, whereas X-ray crystallography only provides static crystal 
structures. Comparing to NMR, HDX-MS is not restricted by the protein size and can 
routinely analyze large proteins of more than 100 kDa, while NMR experiments on proteins 
larger than 40 kD a remain challenging. Latest HDX-MS experiments have reached the 
single-amide resolution. In addition, although considering the total amount of sample 
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required for a complete kinetics experiments (500 - 1000 pmol) [93] it is not totally 
convincing that HDX-MS consumes significantly less samples, this method is amenable to 
studying proteins that are hard to purify or that can only be handled at low concentrations (as 
low as 0.1 μM).  
However, due to the nature of the HDX method, it can provide information only related to the 
amide backbone, and cannot reveal the structural information in three-dimension. One cannot 
therefore rely on HDX-MS alone to resolve a protein structure issue; rather, it should be used 
in combination with complementary structural information from other technologies (both 
experimental and computational) to generate models of large protein complexes.   
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1 Pathway of eukaryotic translation initiation 
In all kingdom of life, the translation is the process by which mRNA is translated into 
proteins. Here a brief summary of this process is presented according to a review by 
Hinnebusch in 2006. [1] In eukaryotes, the initiation of this process is understood to undergo 
the following pathway: it begins with the production of free 40S ribosomal subunits (Figure 
1). A ternary complex (TC) of eIF2, GTP and Met-tRNAi
Met binds to the 40S subunit, 
forming the 43S pre-initiation complex (PIC) through stimulation of eIF1, eIF1A, eIF3 and 
eIF5. The 43S PIC reacts with the m7G-capped 5’-end of the mRNA, stimulated by the cap-
binding protein eIF4E and its partners in the eIF4F complex, as well as the poly(A)-binding 
protein (PABP). eIF4G is the scaffold subunit of eIF4F and has additional binding sites for 
eIF4A (ATP-dependent RNA helicase) and (in mammals at least) for eIF3. Then comes the 
scanning of 43S PIC for an AUG start codon, a process stimulated by eIF1, eIF1a and eIF4G. 
When secondary structure is contained in the mRNA leader, this process also needs eIF4A, 
eIF4B and ATP hydrolysis. The GTP bound to eIF2 in the scanning complex is hydrolyzed to 
GDP in an eIF5-dependent manner; however, release of Pi from eIF2–GDP–Pi is prevented 
by eIF1 until an AUG start codon enters the ribosomal P-site and base-pairs with the 
anticodon of Met-tRNAi
Met. eIF1 is released from the P-site upon r ecognition of the start 
codon, enabling the 48S PIC to assume a closed conformation and thereby it no longer scans 
the mRNA and it triggers the Pi release. The rest of the eIFs are released when the 60S 
subunit joins to form the 80S complex stimulated by eIF5B•GTP. Catalyzed by eIF2B, the 
eIF2•GDP turns back to eIF2•GTP for a new initiation cycle. 
Recycling of eIF2•GDP by eIF2B is prevented under stress or starvation conditions by 
phosphorylation of a subdomain of eIF2, eIF2α. The reduction in TC assembly decreases the 
rate of general translation initiation, but accelerates the translation of specialized mRNAs, 
e.g. GCN4 or ATF4, which contain upstream open reading frames (uORFs) in their leaders 
and encode stress-induced transcriptional activators. Assembly of eIF4F, and thus its binding 
to the mRNA cap, is also downregulated upon starvation or lack of insulin in mammalian 
cells by a mechanism involving the eIF4e binding protein (4E-BP), which competes with 
eIF4G for binding to eIF4E. The inhibitory function of 4E-BP is controlled by the 
mammalian kinase mTOR and is overcome in nutrient-repleted, insulin-treated cells as a 
mean of stimulating protein synthesis rates under these conditions. 
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Some mRNAs are translated by an alternative mechanism, i.e. internal initiation, in which the 
40S ribosome binds directly to an internal ribosome entry site (IRES) located close to the 
start codon, circumventing the requirement for the m7G cap and eIF4E and, depending on the 
IRES, some or all of the other eIFs. 
 
Figure 1 The eukaryotic translation initiation pathway. [1] 
2 The role of eIF3 in translation initiation 
In the above model, at least 12 different eukaryotic initiation factors (eIFs) are involved. eIF3 
was one of the first identified initiation factors in the 1970s [2-3], and it is now proven that 
most of the reactions in the initiation pathway are stimulated by eIF3.  
The best-studied function of mammalian eIF3 is that it c an bind to the 40S subunit and 
inhibits its interaction with the 60S subunit, which is crucial for the formation of the 43S PIC. 
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Recent studies showed that this function of eIF3 is enhanced by other factors including TC 
[4-5], a combination of eIF1 and eIF1A [6], and RNA oligonucleotides. Regarding the 
binding region, several cryo-EM studies revealed that in the interaction of mammalian eIF3 
with the 40S subunit, one ‘leg’ of eIF3 extends close enough to the interface surface to 
disrupt the intersubunit contact activity with 60S. [7-8] 
In the subsequent step, mammalian eIF3 is shown to promote TC assembly under conditions 
of limiting Met-tRNAi
Met. In reconstituted mammalian systems, eIF3 stimulates binding of 
TC to the 40S subunit. [4-5] In a reconstituted yeast system, eIF3 and eIF5 both enhance TC 
binding to the 43S PIC, which has a lower affinity for TC than has the 48S PIC. [9] When it 
comes to the scanning of mRNA by 43S PIC, mammalian eIF3 stimulates mRNA binding to 
the 40S subunit in vitro [10], and this is implicated by yeast eIF3 studies showing that a 
mutation in eIF3b impairs mRNA binding by the 40S subunit in yeast extracts, which can be 
rescued by eIF3 or the eIF3a–eIF3b–eIF3c subcomplex. [11] Evidences also show that eIF3 
functions as a specialized reinitiation factor in gene-specific translational control, and as a 
platform for signal transduction. [1] 
Therefore, although eIF3 has no known enzymatic activities and might not directly interact 
with tRNAi
Met or the decoding sites on the ribosome, it is possibly acting as a large scaffold 
anchored to the solvent side of the 40S subunit with appendages reaching round to the 
interface surface. [1] 
3 The structure of eIF3 
Consistent with its diverse functions, eIF3 has a complex structure: the mammalian eIF3 is 
made up of 13 non-identical subunits as summarized in Table 1. [1] eIF3 from budding yeast 
contains orthologs of five mammalian eIF3 subunits: eIF3a, eIF3b, eIF3c, eIF3g and eIF3i, 
all of which are essential for translation in vivo. These five essential yeast subunits constitute 
a conserved ‘core’ complex that can execute the crucial functions of eIF3, stimulated by 
eIF3j, a sixth, nonessential, substoichiometric subunit of yeast eIF3. 
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Table 1 Summary of eIF3 subunits in selected eukaryotes. [1] 
Unified 
nomenclature 
S. cerevisiae  Functions 
eIF3aa TIF32 40S binding; eIF4B binding; MFC assembly; TC and mRNA recruitment 
eIF3ba PRT1 40S binding; MFC assembly; TC and mRNA recruitment; scanning 
eIF3ca NIP1 40S binding; MFC assembly; TC and mRNA recruitment; AUG recognition 
eIF3d – 
 
eIF3e – 
 
eIF3f – Possible binding site for mTOR and S6K1 
eIF3ga TIF35 Binding eIF4B and CaMV TAV 
eIF3h – 
 
eIF3ia TIF34 
 
eIF3j HCR1 40S binding; MFC assembly 
eIF3k – 
 
eIF3l – 
 
eIF3m – 
 
a: Core subunits; S. cerevisiae: Saccharomyces cerevisiae 
3.1 MS revealed the overall interaction network of human eIF3 
Because of eIF3’s overall structural complexity and the lack of facile genetic approaches, 
knowledge of many aspects of its structure and function remain elusive. Mass spectrometry 
on the intact eIF3 complex successfully generated a subunit interaction map. [12] Intact eIF3 
was subjected directly to mass analysis in solutions with various ionic strengths. Under lower 
salt concentration (100 mM ammonium acetate), the principle series of charge state peaks 
illustrated that the complex exists as a homogeneous population, with all 13 subunits present 
at unit stoichiometry. The dissociation of eIF3i was already observed at this stage, indicating 
a relatively labile association within the intact complex. In addition, eIF3j, k and m 
dissociated from the complex when the ionic strength or the acceleration in the mass 
spectrometer was slightly increased, and these results suggested that these subunits locate on 
the periphery of the complex. 
Polar and ionic interactions of subunit interfaces can be perturbed when the ionic strength is 
increased. Upon changing the ionic strength, a series of subcomplexes each comprising a 
small number of subunits (≤5) were observed and assigned. Precise subunit –subunit contacts 
were derived by elucidating these results. For example, three subcomplexes: two dimers b:g 
and i:g together with the trimer (b:g:i) were detected in human eIF3, indicating the 
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arrangement of the trimer b:g:i with g in contact both with b and i. Upon using isolated eIF3 
from yeast, pairwise dimers g:i and a:b and the trimer b:g:i were observed when the affinity 
tag is placed on subunit b ( Figure 2). By tagging subunit c, additional subcomplexes were 
assigned as (c:b:i), b:i, b:g, and (c:b:g). These data from yeast can be derived into an 
interaction network for eIF3(a:b:c:i:g) with eIF3b serving as the scaffolding protein 
connecting the remaining subunits a,c,i and g (Figure 2). 
 
 
Figure 2 MS spectrum of the yeast eIF3 isolated by tagging subunit eIF3b. [12] 
Upon similar derivation, three tightly associated modules were generated by manipulating the 
ionic strength, denoted as A(eIF3a:b:i:g), B(eIF3f:h:m), and C(eIF3k:l:e:d:c). eIF3c and h 
provide one of the electrostatic interactions between modules B and C, while the role of 
eIF3c is crucial in recruiting module C to A. Based on MS as well as immuno-precipitation 
(IP) result, interactions between eIF3b:f and b:h are important for the contact of the modules 
A and B. Taking this data together, the authors were able to propose a detailed interaction 
network for the stable interactions within the entire human eIF3 which is shown in Figure 3.  
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 Figure 3 Model of the human eIF3 derived from 27 subcomplexes, IP data, and interactions identified 
in the yeast complex. The complex dissociates into distinct modules in response to changes in ionic 
strength; in this case, the spectrum shown was recorded at intermediate ionic strength (350 mM 
ammonium acetate). Arrows denote additional interactions not readily represented in this model.[12] 
 
3.2 The atomic structure of yeast eIF3i:b(654-700) 
As described above, the subcomplex of eIF3b:g:i participates in many steps during the 
initiation process. Despite its physiological significance, the structural information on this 
complex remains incomplete. The eIF3b is one of the major scaffolding subunits of eIF3 and 
associates with the other core subunits in both yeast and mammals. [12-14] Its N-terminal 
domain (NTD) contains a conserved RNA recognition motif (RRM) [15-16], which interacts 
with the C-terminal half of eIF3a and the NTD of eIF3j. Its middle domain is predicted to 
fold into two β-propeller structures [17], the second of which binds to eIF3c. Finally, the 
extreme C-terminal domain (CTD) of eIF3b is required for the binding of eIF3g and i. [14] 
While eIF3i is predicted to adopt a seven-bladed β-propeller structure made up of seven WD-
40 repeats, eIF3g interacts with eIF3i and eIF3b through its NTD containing a predicted Zn-
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finger domain [14], and its CTD contains another RRM not involved in any subunit-subunit 
interactions. 
In 2012, during the course of this thesis, the first crystal structure of one subunit was reported 
among the core subunits in yeast eIF3: the eIF3i subunit in complex with the minimal CTD of 
eIF3b(654-700), and the binding region was resolved by solution X-ray crystallography. [18] 
The minimal C-terminal eIF3i-binding site of eIF3b(654–700) could be determined by X-ray 
crystallography, which does not contain any random coil segments that hinder crystallization. 
The crystallographic structure of this optimized yeast eIF3i:b(654–700) complex was 
determined at 2.2 Å.  
 
Figure 4 Structure of eIF3i:b(654–700). A: Schematic drawing of the predicted protein domains of 
yeast eIF3i (top) and eIF3b (bottom). The folded domains and their boundaries are indicated. 
Predicted unstructured regions are shown as lines. B: Overview of the structure: i (green) and b(654–
700) (blue). C: Topology diagram of i fold. [18] 
The eIF3i shows a seven-bladed β-propeller structure with a short and bent C-terminal α-
helix (Figure 4 A, B). One strand of blade 7 is formed by N-terminal residues 1-7, while the 
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subsequent amino acid residues consecutively form blades 1–7 (Figure 4 C). The eIF3b(654–
700) fragment binds to the bottom side of the β-propeller along the loops of blades 5 and 6 of 
eIF3i (Figure 4 B). Residues 663-689 in eIF3b form a long α-helix while the extended C-
terminus (residues 690–699) advances towards the central cavity of the β-propeller in eIF3i.  
 
Figure 5 Molecular details of eIF3i:b interactions (eIF3i in green and eIF3b in blue). A: Y677 and 
R678 in eIF3b interact with D207, T209 and D224 in eIF3i via hydrogen bonds (shown in dark blue). 
Other residues making contacts (light blue) via main chain atoms are also shown in sticks. One water 
molecule (shown in dots) is in close proximity (light pink) to R678 (2.6 Å) and Y677 (3.3 Å). B: eIF3b 
W674 is surrounded by hydrophobic and charged amino acid residues in a shallow pocket. [18] 
This work also revealed the detailed binding surfaces according to the crystallographic 
results. Seven residues of the b(654–700) fragment are in close contact with eight eIF3i 
residues (<3.5 Å apart). Hydrogen bonds are formed between the most conserved residues 
Y677-D224 and R678-D207/T209 (Figure 5 A), and therefore these residues are crucial for 
eIF3i:b complex formation. The second important feature is the insertion of the aromatic ring 
of b W674 into a pocket of eIF3i formed by hydrophobic amino acids (L231 and I281 as well 
as the conserved L222) and the side chains of polar amino acids (Y210 and K280 as well as 
the conserved K232 and E250) (Figure 5 B). In addition, there is a series of interactions 
between main chain atoms of the extended C-terminal part of eIF3b from N690 and eIF3i 
residues in blades 5 and 6.  
Despite this information, little is known about the structure and interactions of the 
subcomplex of eIF3b:g:i. In this work, we tried to unveil the binding of eIF3i:b and eIF3i:g 
using the method of HDX-MS and the partially resolved atomic structure of 3i:b. 
 
A B 
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4 Synthesis and purification of proteins of interest 
In this work, three proteins or protein segments are independently studied: full-length subunit 
eIF3i with a His-tag at the N-terminus, C-terminal segment of eIF3b(641-724) with a His-tag 
t the C-terminus and N-terminal segment of eIF3g(42-170) with a His-tag at the N-terminus, 
the sequences being shown in Table 2. They will be referred to as eIF3i, eIF3bC3 and 
eIF3gC1ΔC through the work, respectively.  
Table 2 Sequences of proteins synthesized in this work. 
Protein / Mw Sequence 
eIF3i / 40918.7 Da MGSSHHHHHHSSGLVPRGSHMKAIKLTGHERPLTQVKYNKEGDLLFSCSK
DSSASVWYSLNGERLGTLDGHTGTIWSIDVDCFTKYCVTGSADYSIKLWD
VSNGQCVATWKSPVPVKRVEFSPCGNYFLAILDNVMKNPGSINIYEIERDS
ATHELTKVSEEPIHKIITHEGLDAATVAGWSTKGKYIIAGHKDGKISKYDVS
NNYEYVDSIDLHEKSISDMQFSPDLTYFITSSRDTNSFLVDVSTLQVLKKYE
TDCPLNTAVITPLKEFIILGGGQEAKDVTTTSANEGKFEARFYHKIFEEEIGR
VQGHFGPLNTVAISPQGTSYASGGEDGFIRLHHFEKSYFDFKYDVEKAAEA
KEHMQEAN 
eIF3bC3 / 11324.5 Da MLREWSAQFEEQDAMEADTAMRDLILHQRELLKQWTEYREKIGQEMEKS
MNFKIFDVQPEDASDDFTTIEEIVEEVLEETKEKVELEHHHHHH 
eIF3gC1ΔC / 16199 Da MGSSHHHHHHSSGLVPRGSHMEKVHKSVAERKNWHKYGSEKGSPAGPSA
VTARLGEEVELRLSRNWKQAEEERIQKEKASLTKTGLQCRLCGNDHMTM
NCPFKTILSELSALEDPATNEGGVEAASEEKAGQVGGAGSIPGQYVPPSRR 
 
If one compares the eIF3b CTD used in this work to the fragment for which a 
crystallographic structure was obtained, the eIF3b CTD encompasses residues 641-724 which 
is slightly extended both to the C and N –terminal sides compared to 654-700 fragment used 
in the work by Herrmannová et al. [18] 
A detailed procedure of protein synthesis and purification is described in Part 5: Materials 
and methods. Briefly, for each of the above three proteins, the plasmid was transformed into 
cells and inoculated in E.coli. The harvested cells were disrupted by sonication, and the cell 
extract was centrifuged to get rid of cellular and membrane debris.  
The supernatant was first subjected to fast protein liquid chromatography (FPLC) separation 
using a TALON affinity column. The resin binds specifically with the His-tag proteins, 
whereas the other proteins in the cell-extract went directly in the flowthrough. An example of 
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SDS-PAGE gel image of eIF3i after the TALON separation is shown in Figure 6 (left). eIF3i 
eluted in fractions 43-49 as marked in the black box, whereas the other proteins elutes in 
early fractions such as in fraction 2. 
 
Figure 6 SDS-PAGE gel image of eIF3i after FPLC with TALON (left) and Superdex75 (right), 
marked with collected fraction numbers. Left: 2: proteins flowed through the colume. M: standard 
protein markers. 43-49: peak fractions containing eIF3i and de gradations. Right: M: standard 
protein markers. 50: peak fraction of aggregations. 62-72: peak fractions containing pure eIF3i. 
The eluted peak fractions were then applied on a 20 m L Q-Hiload column, to which the 
nucleic acids bound a nd the protein directly flowed through. The collected fractions were 
concentrated up to 5 mL and applied onto a gel-filtration Superdex75 column. This column 
allowed the separation of larger size protein aggregates and the pure protein of interest was 
collected (example shown in Figure 6 (right)). The pure protein fractions were concentrated 
and the concentration was estimated by measuring absorbance at 280 nm. 
 
Figure 7 Separation of dimeric compex eIF3i:gC1ΔC. Left: FPLC spectrum with peaks of the 
eIF3i:gC1ΔC dimer (first) and excess of eIF3i monomer (second). Right: SDS-PAGE gel image. M: 
standard protein standard. gC1ΔC: reference band of eIF3gC1ΔC. i: reference band of  eIF3i. 
i:gC1ΔC: two peak fractions from the first peak in the left spectrum. I(2): peak fraction from the 
second peak in the left spectrum. 
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Once the eIF3i, eIF3bC3 and eIF3gC1ΔC were independently purified, two dimeric 
complexes, eIF3i:bC3, eIF3i:gC1ΔC and a trimeric complex eIF3i:bC3:gC1ΔC were 
generated by mixing the subunits with a 20% excess of one subunit. The mixture was 
subjected to another FPLC separation with the Superdex75 column, and the complex eluted 
in earlier fractions. Figure 7 shows an example of eIF3i:gC1ΔC in the Superdex75 separation. 
As isolated on the gel, the fractions corresponding to the first peak contain a stoichiometric 
complex of eIF3i and eIF3gC1ΔC, indicating the presence of a stable dimer in these 
fractions. 
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1 Initial workflow of HDX experiments and data processing steps 
The basic methodology followed in this thesis derives from a previous work by 
Magalie Duchateau [1], including the exchange step and digestion strategy, the 
chromatography gradient, the FT-ICR mass measurement and the data processing. In 
this section, the methods followed for this work will be detailed, with an emphasis on 
the improvements added to the original methodology. 
1.1 The HDX-MS experiments 
A complete discussion of the experimental condition optimization has been performed 
in a previous PhD thesis in our group [1] and the adapted protocol in this work is 
described in details in Chapter 5 “Materials and methods”. Briefly, the experimental 
session starts with the incubation of a purified protein sample in D2O on ice, where 
the deuterium exchange takes place. After various durations, the deuterated protein 
sample is mixed with an identical volume of 6% AcOH in H2O on i ce, which 
quenches the exchange reaction.  
In the initial protocol, the deuterated protein samples were rapidly frozen by liquid 
nitrogen and stored at -80 °C, and are thawed shortly before the analysis. This was 
convenient for experimental handling and for saving protein samples, as all deuterated 
samples could be prepared with enough replicates within two days and a smaller 
amount of protein samples were consumed. However, back-exchange may be induced 
during the freezing and thawing steps. Thus in this work, after having encountered 
some major issues with the freeze / thaw protocol, instead of performing the 
deuteration of protein with the amount required for all the kinetic points and replicates 
and taking aliquots of proteins out of the deuteration solution, we decided to perform 
each deuteration experiment separately: deuteration of protein with the amount 
required for one LC-MS acquisition is performed, and the deuterated samples are 
digested by pepsin immediately after quenching. The peptic digests are then 
immediately injected into the nanoLC system and analyzed by FT-ICR MS. In a 
separate experiment, unlabelled proteins are digested by pepsin and measured 
similarly. These data are used as the reference data to allow the identification of the 
peptides within the deuterated samples. 
69
1.2 Initial data processing workflow 
Figure 1 illustrates the data processing workflow that was used in the previous work 
and adapted at the beginning of this work. 
 
Figure 1 Initial data processing workflow.  
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1.2.1 Retention time correction 
The data processing starts with the acquisition of the LC-MS spectra of unlabelled 
protein digests (referred to as “reference peptides” from here on) and exchanged 
protein digests. As the gradient of the chromatography was designed to be 
accomplished as quickly as possible, a retention time correction was necessary to 
account for some time shifts between chromatograms and allow the use of the 
retention time for peptide identification. For each protein or protein complex, three 
peptides were selected based on the following criterion: first, they should be present 
in all chromatograms; second, they should be peptic auto-digested peptides which 
present a low deuterium incorporation level. Their experimental retention times were 
extracted from the extracted ion chromatograms (EICs) as t1, t2 and t3, respectively. 
Once all the t1, t2 and t3 from the n sets of experimental data were listed, the average 
retention time of each peptide was calculated as 𝑡1� , 𝑡2�  and 𝑡3� : 
𝑡̅ =  ∑ 𝑡𝑛1
𝑛
                                                                  (1) 
The difference for each t and 𝑡̅ was calculated as 
 Δt = t - 𝑡̅                                                                   (2) 
and a least square approximation was carried out based on Δt and 𝑡̅. 
Δt = a•𝑡̅ + b                                                              (3) 
where  
a =  ∑ (𝑡𝚤�−?̿?)(𝛥𝑡𝑖−𝛥𝑡���)31
∑ (𝑡𝚤�−?̿?)231                                                     (4) 
b = 𝛥𝑡��� - a•𝑡̿                                                         (5) 
with 𝑡̿ representing the average value of 𝑡̅. Thereby the chromatogram realignment 
parameters α and β for each chromatogram were calculated as  
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α = - 𝑏
𝑎+1
                                                             (6) 
β = 
1
𝑎+1
                                                             (7) 
All experimental retention times were then corrected as 
tcorrected =β•texperimental +α                                              (8) 
1.2.2 Establishment of the peptide reference list 
The bottom-up HDX-MS is based on the measurement of deuterium exchange of each 
peptide in the enzyme (pepsin in most cases) digest. In order to correctly assign an 
exchanged peptide isotope envelope to a given peptide, a pre-established peptide 
reference list is required. This list will allow peptide identification based on its 
accurate mass and its retention time.  
In the initial workflow, the peptide reference list was established as follows:  
Experimental peaks were extracted and time-grouped from the raw LC-MS spectra of 
reference proteins with information on m/z, charge state, retention time and intensity 
for each isotopic distribution identified in the initial data. As LC/MS made it difficult 
to introduce internal calibration during the whole LC run, an internal recalibration 
was performed based on the theoretical peaks from an unspecific digest of the protein 
of interest. For this procedure, a 20 ppm  mass accuracy was used for inclusion of 
peaks in the calibration list. After recalibration, assignment of experimental peaks to 
putative peptides (derived from the protein sequence) was also performed with a 20 
ppm mass error tolerance.  
Due to the extreme complexity of pepsin digest caused by its lack of strict specificity, 
this procedure was not accurate, and a high number of ambiguous peak identification 
always occurred. An ambiguous peptide, as used further in the manuscript, is 
designated as an experimental mass peak that can be assigned to at least two possible 
peptides from the protein (or proteins) of interest. The initial strategy to resolve the 
ambiguities was based on the literature preferential specificity of pepsin. According to 
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the nomenclature proposed by Schechter and Berger [2-3] that is used throughout this 
work, the amino acid residues of a protein digested by an enzyme are designated as P1, 
P2, P3 and P4 on the N-terminal of the cleaved peptide bond and P1', P2', P3', P4' on 
the C-terminal. The corresponding residues as the reacting sites on the enzyme of 
pepsin are designated as S1, S2, S3 and S4 on the N-terminal and S1', S2', S3', S4' on 
the C-terminal. Pepsin cuts preferably with Phe, Tyr, Trp, and Leu in the P1 or P1’ 
sites (Figure 2, top). [4] Inhibition of cleavage is observed in the presence of Arg, Lys 
or His at the P3 site. This inhibition is also observed when Arg is located at position 
P1. In addition, the presence of Pro promotes cleavage of the bond at positions P3 and 
P4, but inhibits the cleavage when the latter is in position between P2 and P3' (Figure 
2 bottom). 
 
Figure 2 Scheme of experiential pepsin cleavage preference. Top: favorable cleavage sites. 
Bottom: inhibited cleavage sites. 
Based on these empirical results, a score was assigned to each potential peptide. For 
each peptide, the cleavage probability was considered at both ends. For each end, for 
each residue located in a favorable cleavage position, a positive point was given; and 
for each residue located in an inhibited cleavage position, a negative point was given. 
A peptide was considered valid if both termini were rated greater than or equal to 1. 
Also a peptide is considered potentially valid if one terminus has a rating greater or 
equal to 1 and the other a score of zero. A less specific cleavage at either terminus 
73
was therefore tolerated, and it was considered that the presence of two hydrophobic 
residues at the cleavage site compensated the presence of a Pro or a basic residue in 
inhibiting positions. The scoring process facilitated the selection of potential peptides 
in the cases of ambiguities. This method has been further improved in this work, 
which will be discussed in details in Section 2. 
1.2.3 Peak assignment for deuterated peptides 
Once the reference peptide list was established, it was used to assign the experimental 
data of deuterated samples. After peak extraction, an experimental peak list was 
generated containing m/z, realigned retention time (as described in 1.1) and intensity.  
Such a peak list was difficult to process, as the mass shifted peak patterns by 
deuteration could not be readily assigned using the usual algorithms for high-
resolution data, which validate a measured mass by comparison of the isotopic pattern 
with the reference peptides. Specific software was designed with the home-built 
ProtDBSearch program modules, in order to process the HDX-MS data obtained with 
ppm-order mass accuracy. Figure 3 shows the entry window of the software with all 
parameters that could be customized. 
 
Figure 3 Parameter entry window of the home-built HDX data assignment program. 
The first filter was to find peaks that were likely to belong to the deuterated state of a 
given peptide. The principle (Figure 4) was that for each reference peptide, a f ilter 
was constructed based on the theoretical masses of 𝑀𝐻𝑖
𝑖+ , 𝑀𝐻𝑖
𝑖+𝑑1 , 𝑀𝐻𝑖𝑖+𝑑2 , ... 
𝑀𝐻𝑖
𝑖+𝑑𝑛  with 𝑀𝐻𝑖
𝑖+𝑑𝑛  representing the i time s charged m/z value with n amide 
hydrogen exchanged by deuterium. The value n was determined as the sum of the 
maximum number of possible deuterium, and the number of isotopic peaks whose 
monoisotopic peak intensity was greater than 5% (calculated by a averagine peptide 
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of similar size 1 5[ ]), with an additional 20% margin to allow for partial labeling of 
side chains.  
 
Figure 4 Schematic description of filters (pink) applied on e xperimental peaks (blue). (a) 
Filter to include peaks that may belong to a deuterated peptide. (b) Determination of the 
value n.  
After the first filter, a series of potential experimental peaks is associated with each 
reference peptide. The following filters could be then selected to refine the 
assignment: 
- Retention time 
This filter requires that the experimental peaks lie within a certain window of 
retention time relative to the retention time measured for the reference peptide. A 
regrouping step was also possible at this stage. If a peak appears in several spectra 
within a given retention time range, the m/z values and intensities are replaced by the 
average value (weighted by the intensity) of the m/z and the sum of the intensities.  
- Consistence of isotopic peak series 
1 Rigorously, the mass shift between peaks should be different between 1H/2H, 12C/13C or 14N/15N as 
1.006277, 1.003355 and 0.997035 Da, respectively. In the averagine simulation, an average shift of 
1.0031 between the isotopic peaks for peptides without H/D exchange is applied. This raises a problem 
for the filter, because for low levels of deuteration, an average spacing is close to 1.0031, yet for high 
levels of deuteration, this shift moves gradually to 1.0063. A shift was chosen in our approach as the 
average value of 1.0048 Da. The mass error is thus 1.7 mDa for peaks without H/D exchange and -1.7 
mDa for peaks with H/D exchange, so that for a peptide of 1000 Da, the mass error is within ±1.7 ppm. 
This error is not negligible; therefore in the current state of the program, a mass error tolerance of at 
least 5 ppm should be applied. 
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In an H/D exchange experiment, it was expected that the isotopic series appeared as a 
series of peaks separated by close to 1 Da. This was used as another filter by limiting 
a minimum number of peaks in a series and tolerance of missing peaks within the 
series. Figure 5 illustrated how a g iven series of peaks were selected based on two 
different peak series filters. 
 
Figure 5 Illustration of the isotopic peak series filter. (a) selection upon criterion of at least 
three peaks and maximum one missing peak in the series. (b) selection upon criterion of at 
least two peaks and no missing peak in the series. 
- Pseudo-Gaussian isotopic distribution 
The last filter implemented in the program selects peak series with intensities close to 
a Gaussian distribution. For HDX that follow a EX2 kinetics, a quasi-Gaussian 
distribution can be expected, which does not apply to EX1 kinetics. In addition, 
extreme cases (without exchange or full exchange) are not Gaussian distributed.  
However, with a sufficiently low tolerance (χ2> 0.7), this filter can discriminate noises 
from true signals. It particularly compensates the weaknesses of the previous filters, 
which were not based on intensities, thus a "hole" in a series (e.g. a background noise 
with low intensity in the position of an intermediate mass) may not be readily 
identified, while the series was obviously incomplete or false. The Gaussian filter is 
sensitive to sudden changes in intensity (downward or upward) in a peak series and 
can therefore retain only series with a profile of reasonable intensities. 
The program outputs a list of peptides present in the LC/MS spectra with the 
deuterated mass (intensity-weighted average mass of the isotopic peak series) and a 
complete list of triplets (RT, m/z and intensity) used to calculate the deuterated mass. 
In the situation where the triplets could be attributed to more than one peptide, a label 
is placed and a manual check by the user should be performed to resolve such 
ambiguities. 
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1.2.4 Calculation of deuteration level and kinetics plotting 
Once validated, the deuteration level (%D) of each peptide was calculated as: 
%D = 
𝑑𝑒𝑢𝑡𝑒𝑟𝑎𝑡𝑒𝑑 𝑚𝑎𝑠𝑠−𝑀𝐻𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒+#𝐷𝑚𝑎𝑥                                          (9) 
where the maximum number of exchanged deuterium (#Dmax) for a given peptide was 
calculated as:  
#Dmax = #amino acid residues - 1 - #Pro                                 (10) 
with #amino acid residues being the number of total amino acid residues in the 
peptide and #Pro being the proline residues in this sequence. 
When the deuteration levels for a given peptide at different time points were all 
acquired, they could be plotted against the time, giving a series of points with a 
positive reaction profile of single or double exponential. A curve fitting could be 
carried out according to Eq. 11 in order to determine the rate constants, which has 
been described in 3.4.3 in Chapter 1.  
%Dt = A0 + A1(1 – exp[-k1t]) + A2(1 – exp[-k2t])                     (11) 
2 Method improvements in the establishment of peptide reference list 
At the beginning of this work in October 2010, an FT-ICR mass spectrometer of the 
type Apex III (Bruker, Bremen, Germany) coupled with a 7  Tesla magnet was used 
for MS data acquisition, and the data processing adapted the workflow as described 
above. This instrument was upgraded to an Apex Q platform (Bruker, Bremen, 
Germany) in January 2011, and again to a SolariX platform (Bruker, Bremen, 
Germany) in March 2012. A lthough the superconducting magnet and the ICR cell 
remained the same, these changes in the ion source indeed increased the sensitivity of 
the mass spectrometer, which in turns required changes and improvements to the data 
processing method. 
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2.1 Insufficiency of mass accuracy for peptic peptide identification 
The number of experimental peaks massively increased when the instrument was 
updated from Apex III to Apex Q. A typical LC/MS on a reference protein gave 100-
200 peaks when it was acquired on the Apex III, and the sample of the same 
pretreatment resulted in around 1600 peaks on the Apex Q.  
A large number of peak assignments are thereby generated. An example of the 
reference sample of eIF3i:bC3 is taken to demonstrate the method. Acquired on the 
APEX Q instrument, this data set provides 1596 peaks. It brings around 1600 matches 
after peak assignment to the protein sequence as described in 1.2. The number of 
assignments within each 1 ppm  gap is plotted against the mass error as shown in 
Figure 6 in red. A clear clustering towards the small error region can be observed, but 
a large number of assignments remain in the large error regions, indicating a high 
“baseline” of false identifications.  
 
Figure 6 Error distributions of an example data set of eIF3i:bC3. The number of the assigned 
peaks within certain error range is plotted against mass error. Red: all assignments based on 
the real protein sequence. Grey: all assignments based on the randomized sequence. Purple: 
assignments based on the real protein sequence with POc values lower than the POc limit. 
Green: assignments based on the real protein sequence with POc values higher than the POc 
limit. 
To better access the level of false identification, a randomized sequence was 
generated. This sequence is composed with the same amino acid residues as 
0 
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eIF3i:bC3 but in a totally random order. The example data set is assigned with this 
“fake” sequence, giving around 1200 matches. These matches distributed along the 
mass error as the grey curve in Figure 6. No obvious clustering is observed for these 
assignments and an average of 30 assignments using the randomized sequence within 
each 1 ppm region indicates that within the assignments using the real protein 
sequence, similar number of false assignments is likely to be embedded.  
The larger the protein is, the more complex the digest becomes, and therefore the 
more assignments can be matched in the LC/MS data. Such increases in the number 
of assignments are shown in Table 1, together with the increases of false assignments 
analogized by the number of assignments using the randomized sequences.  
Table 1 Examples of peak assignments for proteins with different sizes. 
 
eIF3bC3 eIF3i:bC3 aIF2Mj 
No. of AAs  93 460 817 
Mw (kDa) 11.3 52 91.4 
No. of assigned peaks with real 
sequence (±5 ppm)  
224 664 778 
No. of assigned peaks with 
randomized sequence (±5 ppm)  
21 429 455 
 
The standard strategy to reduce these false assignments is tandem MS. In order to 
retain the RT information for the peak assignments of the HDX data, LC-MS/MS is 
usually carried out in the same LC condition as for the HDX sample. Such a fast 
gradient brings difficulty to the MS/MS experiment as the number of peptides 
coeluting within a short time range can be much more than those with a long gradient, 
which is the common case for standard proteomics MS. The harsh LC condition, as 
well as the fact that peptic peptides are much more difficult to fragment than tryptic 
peptides, make it difficult to generate a p eptide reference list with high sequence 
coverage and rich sequence overlaps.  
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2.2 Pepsin specificity as another approach for peptic peptide 
identification 
2.2.1 Probability of occurrence of a peptide 
We have described the method in the initial data processing workflow using pepsin 
specificity to validate the identified peptides in 1.2. This prototype of specificity filter 
is further developed is this work. In 2008, a  study was reported based on a l arge 
number of MS/MS results of porcine pepsin digests under conditions compatible with 
hydrogen/deuterium (H/D) exchange (<1°C, <30 s on immobilized pepsin column) [6]. 
The observation of favorable and inhibited cleavage sites is coherent with previous 
observations, and importantly, this statistical analysis provided a table of probability 
of cleavage at different sites (Table 2). The residue on P1 is read from the column and 
the residue on P1’ is read from the line. For example, the cleavage between F-Y is 
observed in 65% of the cases, while between Y-F it is observed in 33% of the cases. 
Table 2 Pepsin specificity by P1-P1’ positions [6]. 
 
By itself, these data do not allow readily an inversion. The percentages given above 
represent only the fraction of sites for which at least one cleavage was observed in the 
experimental data set relative to the total number of these types of sites within the 
observed data. This is not directly extendable to the proportion of cleavage at a given 
position since this value does not include peptides that have been observed to contain 
the intact cleavage site. Our method is based on a postulate: the data given above, 
although not strictly measuring the probability that pepsin cleaves at a given site, can 
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be used as such. It is quite obvious that for the lowest values of 0% is the same. But 
on the other hand, the highest values are likely to be overestimated, as in the 
conditions used for pepsin digestion in H/D exchange, only partial digestion is 
generally performed, and rates of cleavage on the order of 85% at a g iven site are 
quite rare. 
Nevertheless, the choice was done to perform a statistical prediction of peptides based 
on the values given in the above table, to check if such an approach was valuable. In 
the case of good results, a further work could encompass including a true “probability 
of cleavage” at a specific site. This work would not be straightforward at all: the 
intensity of the peptides should be taken into account, which would be problematic 
considering varying ionization and measurement efficiencies between peptides, 
inclusion of both very small and very large peptides in the data set, …  
Assuming that we can use the probabilities given in Table 2 as the ratio of cleavage 
versus non-cleavage at a g iven site, we therefore define a term, probability of 
occurrence (POc), representing the probability for a given peptide from a known 
protein sequence to be present in the peptic digest. The algorithm to generate this POc 
value is as follows: 
A table containing all the sequences that have to be processed is kept and associated 
with its probability Pb-e (b is the index of the N-terminal residue and e that of the C-
terminal residue). This table is initialized with the complete protein and a probability 
of 1. 
The possible cleavage sites are processed from the N-terminal to the C-terminal, 
although the results are the same if the processing is done the other way around. The 
peptides are denoted by their starting and ending position relative to the numbering of 
residues in the sequence.  
1°) The probability of cleavage at this position (Pcurrent) is looked up in Table 2, based 
on the residues present in position P1 and P1’ relative to the current site. 
2°) For each peptide in the sequences table that have the current cleavage position (all 
peptides except those that have their C-terminus before the current positions), which 
has a s tarting (N-terminal) position b and an ending position e (C-terminal) three 
peptides are generated: 
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- A N-terminal peptide ranging from position b to the current position, the 
probability of which is calculated as: 
𝑃𝑏−𝑐𝑢𝑟𝑟𝑒𝑛𝑡 =  𝑃𝑏−𝑒  ×  𝑃𝑐𝑢𝑟𝑟𝑒𝑛𝑡                                           (12) 
- A C-terminal peptides ranging from the current position the position e for which 
the probability is calculated as follows: 
𝑃(𝑐𝑢𝑟𝑟𝑒𝑛𝑡+1)−𝑒 =  𝑃𝑏−𝑒  ×  𝑃𝑐𝑢𝑟𝑟𝑒𝑛𝑡                                           (13) 
- The probability for the current peptide to remain non-cleaved is also updated to 
remove the probability of cleavage described previously, thus the new Pb-e is 
updated as follows: 
𝑃𝑏−𝑒 = (1 − 𝑃𝑐𝑢𝑟𝑟𝑒𝑛𝑡) × 𝑃𝑏−𝑒                                            (14) 
3°) As several peptides in the table can lead to the same peptide after cleavage, the 
table is merged by adding together the probabilities for all peptides having the same 
N-terminal and C-terminal position. 
4°) In order to improve algorithm speed, peptides with a score below a given 
threshold are removed from the peptide sequence list. The user can enter the lowest 
POc value that should be considered as relevant (10-12 is used in this work). The 
threshold is set based on this threshold and on the length of the protein at: 
𝑇ℎ𝑟𝑒𝑠ℎℎ𝑜𝑙𝑑 =  1#𝑟𝑒𝑠𝑖𝑑𝑢𝑒𝑠 𝑖𝑛 𝑝𝑟𝑜𝑡𝑒𝑖𝑛  (𝑈𝑠𝑒𝑟 𝑑𝑒𝑓𝑖𝑛𝑒𝑑 𝑚𝑖𝑛𝑖𝑚𝑢𝑚)2                (15) 
5°) Peptides that have their C-terminal end before the current position will not be 
altered further and are placed in a separate list to speed up further processing. 
6°) Iteration goes back to step 1 increasing current position by one unit, until the C-
terminus is reached.  
A schematic of the algorithm for a 4 residue peptide is provided in Figure 7 to help 
understanding the process. 
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 Figure 7 Example scheme of the algorithm for POc generation. 
As can be seen in Figure 7, the two step process allows mimicking a processing by 
enzyme. The resulting values lead to having the probability of cleavage for each site 
equal (up to the approximation level) to the sum of POc values for peptides C- (or N-) 
terminated at this site.  
As will be described further, the initial values were exactly those found in the Table 2. 
After some work and validation, some MS/MS validated peptides were found that did 
contain a cleavage position for which a value of 0% was present in the table. This was 
to be expected, as quite obviously the quality of Table 2 is dependent on the statistics 
for each cleavage position. The choice was then done to increase all values at 0% in 
Table 2 to 0.5%. This did not strongly alter the results for most peptides, but led to 
consider some peptides that had a high probability for cleavage at one end and a 0% 
probability at the other end, which were otherwise attributed a POc of 0. 
2.2.2 POc filter and mass error filter 
Once an LC/MS data set is assigned with the protein sequence to a list of peptides all 
labeled with the POc value, a POc filter is used as a first selection. As shown in 2.1, 
five randomized sequences are generated and used to assign the experimental data, 
and the average number of resulting matches, #peptiderand, is taken as the analog of 
the false assignment rate. The POc threshold is then set as that the number of 
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assignments with POc values below this limit is equal to the number of false 
assignment: 
#peptiderand = #peptidelow POc                                                                                (16) 
and these low-POc assignments are excluded from the list. The green and purple 
curves in Figure 6 show the population distribution of the assignments with POc 
values above and below the threshold, respectively. The excluded population 
distributes randomly along the mass error value, while the POc-survived population 
clusters clearly within the small mass error range with a much lowered baseline, i.e. a 
significantly reduced false identification level.  
Within the high-POc assignments, a narrower mass error tolerance is then applied, 
decided upon t he performance of the instrument. Throughout this work, a ±7 ppm 
mass filter is used on data acquired in the APEX Q F T-ICR MS, although this is 
higher than the commonly achievable mass resolution for FT-ICR mass spectrometer. 
It is fixed based on the trend in the green curve in Figure 6, as the assignments cluster 
within the ±7 region.  
 
Figure 8 Plotting of peak assignments with POc values against mass errors. Green: 
assignments survived in both filters. Purple: assignments excluded by either of the two filters. 
The green dotted line shows the POc threshold for this data set. 
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Figure 8 is a d etailed plotting of the POc value against the mass error for each 
assignment in an example data set. The points in purple are excluded due to low POc 
and/or high mass error, whereas the green points are kept at this stage. The random 
distribution of the purple data points is a proof of the efficiency of these filters. 
2.2.3 Resolving ambiguous assignments 
Due to the complexity of the pepsin digest, it often occurs that one experimental peak 
can be assigned to more than one peptide, the mass differences of which are within 
the mass error tolerance and therefore not easy to distinguish. The above filters 
significantly reduced the number of ambiguities, however, not completely. Table 3 
shows several examples of ambiguities present in the list after the POc and mass error 
selections. All these experimental peaks are present in both the spectra acquired in the 
HDX-MS standard condition as well as a validation LC-MS/MS run and detected by 
MS/MS (see experimental details in Chapter 5). 
Table 3 Example of ambiguous peak assignments. 
Experimental m/z 
MH+ of 
possible peptide 
Mass error / 
ppm 
POc 
Peptide 
position 
Sequence 
590.2582 (eIF3i) 
1179.5099 -0.54 0.027 99-109 WDVSNGQCVAT 
1179.5099 -0.54 0.0076 100-110 DVSNGQCVATW 
813.3744 (eIF3bC3) 
1625.7249 5.28 0.023 53-66 KIFDVQPEDASDDF 
1625.7249 5.28 0.014 52-65 FKIFDVQPEDASDD 
1094.5107 (eIF3i) 
1094.5153 -4.16 0.091 298-305 YHKIFEEE 
1094.5054 4.88 0.034 340-347 HHFEKSYF 
 
On the other hand, for the examples in Table 3, each peak relates to two possible 
peptides that both survive in the previous two filtering steps. The peak at 590.26 can 
be assigned to two peptides in neighboring positions (eIF3i(99-109) or eIF3i(100-110)) 
with exactly the same mass. MS/MS detected the presence of eIF3i(99-109), which 
does have a higher POc value than the other. However, for the peak at 813.37, 
initially three peptides can be assigned: eIF3bC3(52-65), eIF3bC3(53-66) or 
eIF3bC3(63-76). The last peptide has a mass error of 3.87 ppm , but its POc value, 
0.0003, is lower than the POc threshold, and is therefore excluded, which is indeed 
not detected by MS/MS, providing an example of the efficiency of the POc selection. 
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Figure 9 shows the MS/MS spectra of 813.37 a ssigned to the rest two neighboring 
sequences. The spectrum on top contains a rich series of b-ions (red) and some y-ions 
(blue) that firmly validates the presence of the peptide eIF3bC3(52-65), yet the peaks 
marked in green belong to the fragments of the other peptide eIF3bC3(53-66), 
indicating that these two peptides are both present and coelute in the long gradient 
conditions used for the MS/MS validation work.  
 
Figure 9 MS/MS spectra of parent ion 813.37 assigned to two neighboring peptides. Peaks 
labeled in red, blue and green correspond to b-ions, y-ions and ions from the other sequence, 
respectively.  
Therefore, when it comes to the cases where one peak can be assigned to two (or 
more, although this was never observed) peptides with neighboring sequences of POc 
values both above the POc limit and of exactly the same mass, it can be true that both 
peptides are present in the digest, or at least one of them is present. In the latter 
situation, the peptide not present in the digest is indeed a false identification. 
Nevertheless, including such peptides in the reference list does not introduce 
significant error to the structure elucidation step; because the correct sequences are 
always in the reference list and the false sequences induce only a shift of one amino 
acid residues. On the contrary, if all such ambiguities are excluded, a decrease of 
sequence coverage or sequence overlaps cannot be avoided, and a loss of spatial 
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resolution becomes consequential. We thereby decided that in such cases, both 
sequences are retained in the reference list yet in a m arked group, so that in later 
analysis appropriate caution will be taken in the data interpretation for these peptides 
and regions. 
Table 3 also shows an example of another type of ambiguity, where one peak is 
assigned to two completely different sequences which both meet the criteria for the 
two filtering steps, for example the peak at 1094.51. MS/MS detected only the peptide 
of eIF3i(298-305) which has a POc value higher than the other. However in such 
cases it is  harmful to hazard that the sequence with higher POc value should be the 
correct assignment, because the difference between the POc values can be rather 
insignificant. We decided to exclude the peaks with such ambiguities, in order not to 
introduce spatial errors for later analysis. 
2.2.4 Reproducibility control 
Due to the lack of definite specificity of pepsin, the peptic digestion is not strictly 
reproducible between different experimental replicates. However, given that the 
digestion condition remains the same throughout this work, a high reproducibility is 
still achieved. Therefore a reproducibility control is introduced as the last step to 
establish the reference list: the experiments for each reference protein are repeated 
five times, and a reference peptide is included in the list only when it is present in at 
least two replicates. The chemical noises which randomly occur can be further 
excluded by this filter; yet it does not discriminate against less probable peptides that 
may not be present in all replicates. 
2.2.5 Method validation by MS/MS and evaluation 
In order to validate the method described above, LC-MS/MS experiments were 
performed. It should be emphasized that the LC condition for MS/MS acquisition in 
this work is modified: to achieve maximum peptide detection a 2-hour gradient is 
applied instead of the fast (20 minutes) gradient in standard HDX conditions. After 
each MS scan, the top 20 peaks are selected for fragmentation. The results are then 
subjected to a M ascot database search with the following criterion: no specific 
enzyme, oxidation as variable modification, 10 ppm  peptide tolerance, 0.5 D a 
fragment tolerance. The database search gives a large number of identified peptides, 
87
many of which are repeated as the parent ions are fragmented more than once. After 
refining these replicates and applying a Mascot score limit of 20, a list of 385 MS/MS 
validated peptides is generated with an average Mascot ion score of 49 and standard 
deviation of 21. Compared to the average Mascot ion score of 26 reported in a recent 
work with MS/MS data of a similar-size protein acquired under HDX condition using 
the same mass spectrometer [7] as in this work, we obtained the MS/MS list with a 
higher score. This is most probably due to the extended LC gradient, which reduced 
the effect of critical data acquisition parameters, e.g. longer spectra acquisition time 
are possible and a larger number of peaks are fragmented.  
Figure 10 shows the number of MS/MS validated peptides with different POc values. 
Most of the peptides identified in the MS/MS run are with a POc value above 0.001, 
which is coherent with the POc threshold derived from the analysis of the data shown 
in 2.2.2. This similar distribution of POc values comparing to Figure 7 is a primary 
proof of the validation of the POc value method as well as for the rationality of the 
POc filter. In fact, since the POc values are derived from a statistical analysis of HDX 
MS/MS results, it can be considered as a “theoretical” prediction of MS/MS, within 
the initial approximation assigning a s imilar value to probability of cleavage at a 
given position and probability of at least one cleavage at a given position. The 
distribution in Figure 9 therefore again confirms the accuracy of both Table 2 and the 
POc algorithm. 
 
Figure 10 Population distribution of MS/MS validated peptides in eIF3i:bC3 in a given POc 
range. The blue bar represents the number of peptides detected within the POc range; the 
green number is the number of the theoretical peptides with 4-40 AAs in the POc range; the 
red number is the number of the theoretical peptides of any length in the POc range. 
The peptides in this example retained after the filters are compared with the peptides 
validated by MS/MS. Among the 216 pe ptides from the example data set, 160 a re 
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detected in the LC-MS/MS run. Figure 11 is the plot of the retained assignments from 
the example data set in comparison with the MS/MS identified peptides. It should be 
noted that one peptide sequence may corresponds to more than one assignment due to 
different charge state, and therefore there are 328 data points plotted in Figure 10.  
 
Figure 11 Plotting of peak assignments kept in the reference list with POc values against 
mass errors. Green square: unambiguous assignments validated by MS/MS. Empty green 
square: unambiguous assignment not detected by MS/MS. Orange square: ambiguous 
assignment with neighboring sequences validated by MS/MS. Empty orange square: 
ambiguous assignment with neighboring sequences not detected by MS/MS. 
There are 12 peptides excluded either by the POc filter or the mass error filter which 
are detected by MS/MS, indicating that by excluding the false identifications with the 
filters, it is unavoidable that some real peptides are also excluded. These peptides 
mostly fall in the regions that are close to the POc or mass error thresholds. There are 
peptides detected by MS/MS, the peaks of which are not included in the example peak 
list; on the contrary, some assignments, as marked in the empty squares in Figure 10, 
are not detected by MS/MS. Both cases can be attributed to the experimental 
difference, e.g. digestion, fragmentation, detection. More interestingly, throughout 
this comparison, no f alse identification has been observed: when a MS peak is 
assigned to a peptide, it is either validated by MS/MS or not detected, but never 
proved by MS/MS to belong to another sequence excluded by the filters. This solidly 
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validates the method we developed, as it efficiently reduced the false identifications 
and resolved the ambiguous identifications.  
The improved method to establish the reference peptide list is in principle based on 
two criteria: the mass accuracy and the calculated POc value. While the POc value is 
only dependent in the sequence of the peptide, the mass accuracy varies according to 
the protein size, the LC condition, the sample concentration, the instrumental and 
experimental parameters of the mass spectrometer, etc. In this work, the LC condition 
and the sample concentration remained constant; however, the upgrades of the MS 
instrument significantly increased its performance, as demonstrated before the 
upgrade from APEX III to APEX Q brought marginally higher detection sensitivity. 
The protein size also affect the mass error range, as illustrated in Figure 12. 
 
Figure 12 Error distributions of example data sets of eIF3i:bC3 (left) acquired with APEX Q 
and eIF3gC1ΔC (right) acquired with SolariX. The number of the assigned peaks within 
certain error range is plotted against mass error. Red: all assignments according to the real 
protein sequence. Blue:  assignments that survived the POc selections. 
The data set in Figure 12 (left) is the same example of eIF3i:bC3 (460 AAs) used to 
demonstrate the method, while the data set on the right is of eIF3gC1ΔC (149 AAs). 
Obviously, for eIF3gC1ΔC a narrow error distribution is present even in the initially 
assigned peaks without any selections (Figure 12, right, red curve). The baseline is 
efficiently lowered after the POc selection (Figure 12, right, green curve), and the 
mass error tolerance can be readily decided to be ±4 ppm. Whereas in the other 
example, a ±7 ppm mass error selection has to be applied.  
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Nevertheless, the data acquired with APEX Q and SolariX both meet the quality 
needed for the processing of the deuterated samples. Therefore in this work results 
acquired with both APEX Q and SolariX are equally used. Figure 13 shows the 
sequence coverage of the reference peptide lists for eIF3bC3, eIF3gC1ΔC and eIF3i. 
All lists have high sequence coverage and high spatial resolution due to rich sequence 
overlaps.  
 
Figure 13 Sequence coverage of reference peptide lists of eIF3bC3 (top), eIF3gC1ΔC (middle) 
and eIF3i (bottom). 
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3 Method improvements in the processing of deuterated sample data 
Generally, in this work the data processing other than reference peptide list 
establishment follows the previous workflow. A few modifications have been made 
on the HDX peak assignment and data representation to cope with the instrumental 
upgrade. 
3.1 Mass recalibration 
The FT-ICR mass spectrometer provides data with high mass accuracy and resolution. 
However, under the HDX condition, the mass accuracy is reduced due to the 
following reasons: the mass measurement with fast nanoLC gradient produces large 
number of coeluted peaks with various masses and charge states, and this leads to the 
space-charge effect often observed in FT-ICR MS that induces significant mass error 
[8-11], which is significant in measurements of high mass species with the highly 
sensible instrument. On the other hand, the harsh LC condition leads to a relatively 
poor chromatographic reproducibility, thus the retention time control is weak. Since 
the use of LC prohibits the internal calibration throughout the whole chromatograph, a 
recalibration step of the deuterated sample data is introduced in this work prior to the 
data assignment.  
For each data set, four to six peaks with high intensity are selected. These peaks 
should be with a low deuteration level so that monoisotopic peak is present in all the 
samples at varying deuterium incubation times. They should also cover the entire 
mass range. The reference masses and the experimental masses are entered in a home-
built program with the two calibration parameters (called ML1 and ML2 in the Bruker 
interface) used for the data acquisition. The recalibration parameters are generated by 
linear least squares fitting, and the whole peak list is then recalibrated accordingly. 
3.2 Program upgrades for peak assignments of deuterated samples 
Similar to the situation described in 2.1, the number of peaks in the deuterated 
samples also increased after the APEX Q replaced the APEX III. With samples of 
similar concentrations, typically 3000 – 5000 peaks were extracted from the APEX III 
LC-MS spectra, while from the APEX Q spectra, 30000 – 200000 peaks can be 
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extracted. The complexity of the spectra made it necessary to refine the criteria of 
peak assignment. Figure 14 shows the interface of the updated version of the HDX 
data assignment program used in this work.  
 
Figure 14 Updated parameter entry window of the home-built HDX data assignment program. 
Instead of a high mass tolerance of 20 ppm which was applied previously, a 10 ppm 
tolerance is used as the peaks are recalibrated, yet this cannot be further reduced due 
to the variation of mass error caused by space-charge effect. A 3-minute window of 
retention time is used. Since the detection sensitivity has been enhanced, isotopic 
patterns of less intensive peaks are also better shaped. Therefore the restrictions are 
narrowed: missing peaks are no longer tolerated, a peak series is considered when at 
least three peaks are present, and the minimum Gaussian quality factor is fixed at 0.9 
with an intensity threshold of 8000. In addition, a maximum deuteration level is set 
according to deuteration time, and this helps resolve the overlapping peaks which may 
belong to two different peptides. 
Successfully assigned peaks leads to the deuteration levels of the peptides, which are 
then used to unveil the structural information of the proteins, and this will be 
discussed in the next chapter. 
 
 
93
References 
1. Duchateau, M. Détermination de surface d’interaction d’assemblages biologiques 
macromoléculaires par marquage au deutérium et analyse par spectrométrie de masse 
FT-ICR. Ecole Polytechnique, 2010. 
2. Schechter, I.; Berger, A., On the size of the active site in proteases. I. Papain. Biochem. 
Biophys. Res. Commun. 1967, 27, 157. 
3. Schechter, I.; Berger, A., On the active site of proteases. III. Mapping the active site of 
papain; specific peptide inhibitors of papain. Biochem. Biophys. Res. Commun. 1968, 
32, 898-902. 
4. Keil, B., Specificity of proteolysis. Springer Verlag: 1992. 
5. Senko, M. W.; Beu, S. C.; McLafferty, F. W., Determination of monoisotopic masses 
and ion populations for large biomolecules from resolved isotopic distributions. J. Am. 
Soc. Mass. Spectrom. 1995, 6, 229-233. 
6. Hamuro, Y.; Coales, S. J.; Molnar, K. S.; Tuske, S. J.; Morrow, J. A., Specificity of 
immobilized porcine pepsin in H/D exchange compatible conditions. Rapid Commun. 
Mass Spectrom. 2008, 22, 1041-1046. 
7. Burns, K. M.; Rey, M.; Baker, C. A.; Schriemer, D. C., Platform Dependencies in 
Bottom-up Hydrogen/Deuterium Exchange Mass Spectrometry. Mol. Cell Proteomics 
2013, 12, 539-548. 
8. BenDaniel, D.; Duke, C., Space-charge effects on electron tunneling. Physical Review 
1966, 152, 683. 
9. Easterling, M. L.; Mize, T. H.; Amster, I. J., Routine part-per-million mass accuracy for 
high-mass ions: space-charge effects in MALDI FT-ICR. Anal. Chem. 1999, 71, 624-
632. 
10. Jeffries, J.; Barlow, S.; Dunn, G., Theory of space-charge shift of ion cyclotron 
resonance frequencies. Int. J. Mass Spectrom. Ion Processes 1983, 54, 169-187. 
11. Ledford Jr, E. B.; Rempel, D. L.; Gross, M., Space charge effects in Fourier transform 
mass spectrometry. II. Mass calibration. Anal. Chem. 1984, 56, 2744-2748. 
 
 
94
  
 
Chapter 4 
HDX analysis of the eIF3 complexes 
 
 
 
 
 
 
 
95
1 Peptide selection, centroid mass verification and deuteration level calculation for deuterated 
samples  ............................................................................................................................................. 97 
2 The eIF3i monomer and complexes of eIF3i:bC3 and eIF3i:gC1ΔC........................................... 102 
2.1 HDX of eIF3i monomer  ............................................................................................... 102 
2.2 HDX of eIF3i in complex with eIF3bC3 ....................................................................... 106 
2.3 HDX of eIF3i in complex with eIF3gC1ΔC .................................................................. 118 
2.4 Discussion...................................................................................................................... 127 
References ....................................................................................................................................... 129 
 
 
 
 
 
 
 
 
 
 
96
As introduced in Chapter 2, the crystal structure of eIF3i in complex with the minimal 
CTD of eIF3b(654-700) was reported in 2012 [1], the second year of this PhD work. 
This significantly facilitates the structural study as deuteration information can be 
analyzed with the help of the atomic structure. In the complex, eIF3i shows a seven-
bladed β-propeller structure with a C-terminal short, bent α-helix. One strand of the 
last blade 7 is formed by N-terminal residues 1-7, while the subsequent amino acid 
residues consecutively form blades 1–7.  
The atomic structure of eIF3i alone is not reported, nor is the structure of the eIF3i:g 
binding surface. Yet there should not be huge structural difference between the free 
form of eIF3i and eIF3i in complex with eIF3b. In this part, the structure information 
by HDX-MS on the eIF3i subunit will be discussed in details upon binding with 
eIF3bC3 and eIF3gC1ΔC. 
1 Peptide selection, centroid mass verification and deuteration level 
calculation for deuterated samples 
The reference peptide list is established using the method described in Part 3. This list 
covers the whole eIF3i sequence except the first residue in the NTD and the five 
residues in the CTD. As shown in Figure 1 a large number of sequence overlaps are 
included in the list, ensuring a sub-peptide level of spatial resolution.  
 
Figure 1 Sequence of eIF3i and sequence coverage of the reference peptide list. 
After automated peak assignments and centroid mass calculation of the deuterated 
peptides according the reference peptide list, a limited number of representative 
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peptides are selected. These peptides are present in all time points and with relatively 
high signal intensity. In addition, these peptides are not coeluting with other peptides 
with similar masses which may interfere with the isotopic peak series. Generally, 
efficient peak assignment and accurate mass calculation are readily achieved for these 
peptides using the automated software. However, a manual check is necessary in the 
“abnormal” cases, i.e. when a significant difference in deuteration level occurs 
between peptides at similar regions or between replicates of same time points.  
 
 
Figure 2 Mass spectra of peptide 89-108 in eIF3i (a) without deuteration and after (b) 5 s, (c) 
1 min, (d) 15 min, (e) 30 min of deuteration. 
Figure 2 illustrates a case for which automated analysis leads to wrong values. It is an 
example of spectra of a triply charged ion with 5 s (b), 1 min (c), 15 min (d) and 30 
min (e) incubation in D2O, as well as the reference spectrum of sample without 
deuteration (a). The original ion with monoisotopic peak at 781.1 (Figure 2 (a), first 
(a) 
(b) 
(c) 
(d) 
(e) 
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peak series) is assigned to the peptide 89-108 of eIF3i, with MH+ = 2341.1785. 
However, there is another adjacent triply charged peak series at 782.8 (Figure 2 (a), 
second peak series), corresponding to a coeluting peptide 263-282 of eiF3i, with MH+ 
= 2346.1865. The two series are well separated in the spectrum without deuteration; 
yet when it comes to the spectra of deuterated samples, the peak patterns become 
quite complex. The overall mass shifts due to deuterium uptake are clearly observed. 
However, the isotopic peak series of the two peptides merge together very early in the 
kinetics. Initially (Figure 2 (b, c)), one could even assume that only the first peptide 
(monoisotopic peak at 781.1) is present. For later time points, at 15 min and 30 min of 
deuteration (Figure 2 (d, e)), two distributions seem to emerge and at first glance one 
might even consider it as a typical EX1 phenomenon. In the automated process, all the 
peaks are taken into the calculation of the centroid mass of peptide 89-108 as all of 
these peaks survive the selection process of the software, which leads to a completely 
invalid result. These two peaks could be separated by two Gaussian fittings. However, 
since there are other neighboring peptides present in the results, such ambiguous peak 
patterns are simply excluded from the data processing in order to accelerate the whole 
data analysis.  
The use of FT-ICR MS and the reference list establishment method ensure peptides 
with a wide range in size to be monitored. Under common conditions, MS/MS is 
readily able to detect doubly and triply charged ions but vulnerable to detect peptide 
ions with higher charge states. Therefore, peptides with masses above 3000 Da are 
rarely present in the reference list established with MS/MS. In this work, MS/MS is 
not used to establish the peptide reference list, so that the size limitation increases up 
to 6000 – 7000 Da, which is no longer restricted by the instrument but by the nature 
of pepsin digest. The high resolution of FT-ICR MS enables it to precisely analyze 
ions with high charge state. Figure 3 shows the mass spectrum of a large peptide 
eIF3i(127-187) with MH+ = 6756.9042 after 30 min deuteration (top) and a zoomed 
view of its 12+ ion peak (bottom). The isotopic series are well separated even for the 
12+ ion, clearly demonstrating the high performance of the mass spectrometer. 
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 Figure 3 Mass spectrum of eIF3i(127-187) after 30 min deuteration with ions detected from 
6+ to 12+(top), and zoomed view of its 12+ ion peak series (bottom). 
The deuteration level achieved in this work is, however, limited by the experimental 
conditions. As demonstrated in Part 1, back exchange of the deuterium to hydrogen 
can occur during the whole process after quench of the exchange reaction, and the 
extent of back exchange is affected by temperature and analysis time, as long as pH is 
kept stable. Due to the limitation of temperature-control devices and lack of 
automation, in this work the low temperature is achieved by on-ice handling of the 
pepsin digestion and ice-water bath of the nanoLC system. In addition, according to 
the gradient optimization result, the latest peaks are acquired 35 min after quenching, 
whereas in other works reported with advanced LC system the data acquisition can be 
finished within 10-15 min after the quench. [2-4] A relatively high level of back 
exchange is therefore unavoidable in this work. 
Examples of high and low levels of deuteration are shown as mass spectra in Figure 4. 
Spectra (a) and (c) are acquired from reference samples without deuteration, and (b) 
and (d) are taken from samples after 30 min of deuteration. The deuteration level of 
eIF3i(243-261) (Figure 4 (a, c)) is calculated to be 45.9%, and that of eIF3i(87-108) 
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(Figure 4 (b, d)) is calculated to be 11.8%. Although various approaches have been 
introduced to correct the back exchange or normalize the deuteration level during data 
processing, here we use the deuteration level in the form of the absolute value in order 
to retain the comparability of data between replicates, different deuteration times and 
different protein complexes.  
 
Figure 4 Mass spectra of peptides with high (left, eIF3i(243-261), MH+ = 1017.5979, doubly 
charged) and low (right, eIF3i(87-108), MH+ = 2511.2841, triply charged) levels of 
deuteration. The top spectra are from samples without deuteration and bottom spectra are 
from samples with 30 min of deuteration.  
Due to the limit of time within this work, the selected peptides in data for 5 s, 1 min, 
15 min and 30 min of deuteration were thoroughly verified as described above. These 
time points are significant as they provide information for short and long deuteration 
time. After the verification of the centroid masses of the selected peptides, the 
deuteration levels are calculated and analyzed together with the atomic structure.  
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2 The eIF3i monomer and complexes of eIF3i:bC3 and eIF3i:gC1ΔC 
2.1 HDX of eIF3i monomer 
The crystal structure of eIF3i monomer is still not reported, and the difficulty in 
crystallization indicates a possibly higher level of flexibility in the structure of this 
subunit. The deuteration level of eIF3i reflects this hypothesis. After calculation of the 
deuteration levels at various time points for the peptides in the digest of eIF3i, the 
HDX profiles are plotted on the protein sequence (Figure 5).  
 
Figure 5 HDX profile of eIF3i monomer after (a) 5 s, (b) 1 min, (c) 15 min, (d) 30 min of 
deuteration. Peptides are color-coded according to the deuteration levels.  
The HDX profile shows the deuteration level of each peptide monitored in this work 
after different time of deuteration. The population of these peptides is significantly 
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smaller to that of the initial reference list as shown in Figure 1, due to the fact that 
only peptides which are present in the majority of the time points are included. The 
spatial resolution is therefore compensated to some extent by higher accuracy and 
reproducibility. This profile provides a direct overview of the deuteration 
corresponding to the protein sequence, from which the first-hand information is 
generated. 
After very short deuteration time (5 s as shown in Figure 5 (a)), the overall 
deuteration level remains below 20%. Higher deuteration levels are found in the 
regions of 108-125, 243-251 and 251-273, indicating higher dynamics and easier 
accessibility to the solvent. As the deuteration time increases, the peptides in the 
regions of 2-62, 108-125, 185-211, 222-242 and 262-298 gradually reach medium 
level of deuteration, i.e. after 30 min of deuteration these regions have 20-25% of 
deuteration. Regions of 63-74, 87-10, 126-188, 211-222 and 317-329 remain with low 
deuteration level below 15%, indicating well-protected and rigid structures which are 
not easily accessible by the solvent. The region of 243-273 consists of several 
peptides all showing high levels of deuteration over 40%, typical for loop regions and 
flexible dynamics and high solvent accessibility. 
In order to correlate the deuteration information with the reported crystal structure, 
two approaches are carried out. The first attempt is to generate an average deuteration 
level for each amino acid residues. As such, if several peptides overlap in a certain 
region, the deuteration information carried by these peptides is integrated and a higher 
spatial resolution may be achieved. However, a loss of precise deuteration 
information may be induced at the averaging step. For example, after 30 min reaction, 
peptide 251-262 shows 32.8% of deuteration, whereas peptide 251-273 shows 27.0% 
of deuteration. If one chooses to average, the averaging of the two peptides gives a 
value of 29.9% for residues 251-262 and 27.0% for residues 263-273. This is indeed a 
problem since if we consider the shortest peptide, an accurate value of 32.8% should 
be considered for 251-262, and one could expand the process by requiring that for 
peptide 251-273, the total 27.0% should be an weighted average between 11 amide 
bonds at 32.8% (peptide 251-262) and 11 amide bonds at x percent (peptide 262-273). 
Application of this calculation leads to a value of 21.2% for the 262-273 region 
instead of 27%. This differential approach is technically correct but hard to 
completely automate: peptide overlaps are not always as simple as in the example 
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Figure 6 The HDX eIF3i in three forms after different times of deuteration color-coded on the 
crystal structure of eIF3i:b(654-700). The 7 blades of the β-propeller are marked and blue-
white-red colors represent low-medium-high levels of deuteration, respectively. The selected 
peptide list is presented on the top. 
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taken here, and sometimes one would have to include 6-7 overlapping peptides, and 
the correct method to extract the final result with the inclusion of experimental errors 
is a difficult problem. [5-6] 
Since the error induced by averaging the deuteration levels can be harmful, and 
extraction of overlapping values is difficult, this approach is not applied in this work. 
Instead, shortest peptides that cover each sequence region and not overlapping with 
each other are first used to plot on the structure model. This selected list of peptides 
are shown in Figure 6 (top). For the sequence gaps between these peptides, 
deuteration levels are taken from shortest peptides that cover these residues.  
Figure 6 (left column) shows the time-dependent evolution of deuteration levels of the 
free from of eIF3i color-coded on the crystal structure model. It has to be noted that 
the reported structure is in complex with eIF3b(654-700), the stability of certain 
regions maybe slightly different from the structure of the eIF3i monomer. Indeed, the 
highly structured β-propeller is in agreement with the initial low deuteration levels in 
Figure 6 (a) and (b). Blade 6 already shows a higher deuteration level due to its rich 
content of loop structure. However, with the evolution of time, the 7 blades show 
different level of deuteration. Blades 1, 5, 6 and 7 are highly deuterated while blades 2, 
3 and 4 remain in a low deuteration level. The highly deuterated residues 108-126 at 
blade 3 may result from the lack of spatial resolution as this value is derived from a 
single long peptide covering the loop region in addition to the residues in blade 3, 
which falsely raises the deuteration of the neighboring β-sheets. Despite this region, 
the HDX of eIF3i monomer leads to the hypothesis that the N- and C-terminal blades 
may have a higher level of flexibility and undergo rapid open-close motions, while the 
inner blades are more rigid and well protected from the solvent access.   
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2.2 HDX of eIF3i in complex with eIF3bC3 
When eIF3i interacts with eIF3bC3 in the complex, the HDX in the eIF3i domain 
changes significantly. An overall decrease of deuterium incorporation is observed in 
each time point, as the binding of eiF3bC3 inhibits the interaction of eIF3i with the 
solvent water.  
 
 
Figure 7 HDX profile of eIF3i in the complex of eIF3i:bC3 after (a) 5 s, (b) 1 min, (c) 15 min, 
(d) 30 min of deuteration. Peptides are color-coded according to the deuteration levels.  
The HDX profile of eIF3i in the complex of eIF3i:bC3 (Figure 7) shows decreases in 
deuteration levels at various regions. The regions of 63-74, 87-107, 126-188, 211-222 
and 317-329 remain low deuteration levels throughout the whole time course, which 
are similar to the behaviors of these regions in eIF3 monomer. This similarity 
indicates that these regions are not on the binding surface of eIF3i and eIF3bC3.  
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Figure 6 (middle column) illustrates the time-dependent evolution of deuteration level 
for eIF3i in complex with eIF3bC3 color-coded on the crystal structure model of 
eIF3i:b(654-700). Blades 1, 5, 6 and 7 show significantly lower deuteration level in 
the complex indicating that they interact intensively with eIF3b. In addition, the 
binding of eIF3bC3 may stabilize the whole β-propeller structure of eIF3i, as the 
overall deuteration level decreases in comparison to the eFI3i monomer.  
In order to more precisely analyze the binding regions, the difference of the 
deuteration levels for each peptide at the same time point are plotted in Figure 8 for 
data after 5 s and 30 min deuteration. Such plotting provides a clear overview of the 
HDX behavior upon the complex formation. Notably, the data points reflect the 
change in the peptide level, rather than the single residue level. In order to avoid 
misleading errors introduced in the experimental and data processing steps, a 
threshold of ±3% is applied so that only difference larger than this is considered 
structurally significant. The higher values in the plot indicate more significant 
protection in the structure upon the binding with eIF3bC3. According to the nature of 
deuterium exchange on amide hydrogens, the protection can be attributed to the direct 
formation of hydrogen bonds between eIF3i and eIF3bC3, to the inhibition restraining 
access of water molecules towards the amide hydrogen on eIF3i by nearby residues of 
eIF3bC3, or to a higher ordered and less flexible conformation, induced by the 
complex formation. Overlapping peptides with slight residue shifts show similar 
changes and can cross-validate each other, e.g. peptides 222-228 and 223-228 
decrease by 12.1% and 13.2% in deuteration levels after 30 min upon eIF3bC3 
binding, respectively. On the other hand, significant difference between peptides 
which share part of the sequence can be informative: for example, peptide 251-262 
shows a decrease of 10.5% in deuteration level after 30 min, whereas peptide 251-273 
only shows a decrease of 2.5%, and this indicates that the regions 262-273 is not 
directly protected by the binding, although this region is not separately observed as a 
single peptide.  
Representative peptides are selected and analyzed with more precise time points and 
two replicates at each time point: deuteration levels after 5 s, 30s, 1 min, 2 min, 4 min, 
8 min, 15 min and 30 min reaction are studied. Kinetic curves are thereby generated 
and compared with the structure model reported as eIF3i:b(654–700) [1]. It has to be 
stressed that the eIF3bC3 fragment used in our work contains residues 640-726, a 
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 Figure 8 Differences of the deuteration level of peptides in eIF3i of different forms after 5 s 
(blue or green) and 30 min (purple or red) of deuteration. 
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more extended fragment than in the crystallized structure. It consists of the long α-
helix of residues 663-689 which is shown to bind to the bottom side of the b-propeller 
along the loops of blades 5 and 6 of eIF3i, the unstructured chain of 690-699 shown in 
the crystal structure that advances towards the central cavity of the eIF3i b-propeller, 
as well as the N-terminal residues 640-653 and the C-terminal residues of 700-726 
which have not been crystallized yet. 
The peptide eIF3i(243-251) (Figure 9) displays significant change in deuteration 
levels upon the formation of the complex. In the eIF3i monomer, this peptide rapidly 
reaches high levels of deuteration within the first few minutes. A relatively large 
deviation between replicates indicates a highly flexible structure in this region easily 
accessible by the solvent (Figure 9, bottom-right, blue and green). In the eIF3i:bC3 
complex, much lower deuteration levels with less deviation are observed (Figure 9, 
bottom-right, red and purple). These behaviours agree with the structure shown in 
Figure 9, bottom-left. The peptide 243-251 consists of several residues on a β-sheet 
and a loop in blade 6. This loop closely interacts with the C-terminal loop structure of 
eIF3b, via main chain atoms contact between W248 from eIF3i and F694 and D695 
from eIF3b (Figure 9, bottom-middle). This interaction clearly stabilizes the flexible 
loop in eIF3i, and limits the contact of its amide hydrogens with the solvent water 
molecules.  
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Figure 9 HDX of eIF3i(243-251). Top: mass spectra of the isotopic envelop of doubly 
charged ion from eIF3i monomer (left) and eIF3i in the complex (right) before deuteration 
(ref.) and after different times of deuteration. Bottom-left: highlight of the position of this 
fragment on the crystal structure. Bottom-middle: interacting regions with molecular 
details(eIF3i: green; eIF3b: blue) [1]. Bottom-right: Plot of deuteration levels as the average 
(square) of two replicates (triangle) against the deuteration time. Blue and green marks 
represent eIF3i monomer while red and purple marks represent eIF3i in the complex. 
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A similar agreement between HDX data and the reported structure is also found for 
peptides eIF3i(195-210) and eIF3i(222-228), which cover regions that directly 
interact with eIF3b. As shown in Figure 10, both peptides show medium levels of 
deuteration around 20% after 30 min reaction in the eIF3i monomer (top- and middle-
left, blue and green). This may be due to the fact that peptide 195-210 locates near the 
central cavity of the β-propeller and 222-228 consists of rich β-sheet structure, and 
therefore they are both under protection from direct solvent access. Nevertheless, 
significant decreases of deuteration levels occur upon the binding of eIF3bC3 (top- 
and middle-left, red and purple). D207, T209 and D224 from eIF3i form hydrogen 
bonds with Y677 and R678 from eIB3b via side chains (Figure 10, bottom-left) [1]. In 
addition, the aromatic ring of eIF3b W674 inserts into a pocket of eIF3i formed by 
hydrophobic amino acids (L231, I281 and the conserved L222) and the side chains of 
polar amino acids (Y210 and K280 as well as the conserved K232 and E250) (Figure 
10, bottom-right) [1].  
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Figure 10 HDX of eIF3i(195-210) and eIF3i(222-228) in comparison with structure model. 
Top- and middle-left: Plots of deuteration levels with the average (square) of two replicates 
(triangle) against the deuteration time. Blue and green marks represent eIF3i monomer while 
red and purple marks represent eIF3i in the complex. Top- and middle-right: highlight of the 
position of the fragments on the crystal structure. Bottom: interacting regions with molecular 
details(eIF3i: green; eIF3b: blue) [1].  
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The HDX of another peptide, the N-terminal 4-25 in eIF3i, is shown in Figure 11. It is 
reported that one β-sheet of the last blade 7 is formed by N-terminal residues 1-7, 
which contains the N-terminus of peptide 4-25, while the subsequent residues 
consecutively form blades 1-7 [1]. The rich content of β-sheet structure explains the 
medium levels of deuteration of this peptide in the eIF3i monomer. The C-terminus of 
this peptide located in the central cavity of the β-propeller is likely to interact with the 
eIF3b C-terminus, which extends further towards the loop region in eIF3i (4-25). 
Since this region of eIF3b(701-724) is not included in the reported crystal structure of 
eIF3i:b(654-700), in the structure model (Figure 11 bottom-left) no direct interaction 
can be observed. This hypothesis might explain the significant decrease of deuteration 
levels upon the complex formation, and it complements the interaction information 
that was not achieved by previous reports. Peptide eIF3i(26-37) and eIF3i(38-56) also 
exhibit such significant decreases of deuteration (Figure 8), indicating that the long C-
terminus may extend further towards blade 1 in eIF3i. 
Similar HDX behaviour is also observed in the peptide eIF3i(288-300) (Figure 12). 
The relatively high levels of deuteration and deviations between replicates agree with 
a long, flexible loop structure in the middle of the peptide. When the complex forms, 
the deuteration levels decrease. The C-terminal β-sheet structure locates close to the 
central cavity of eIF3i, and is therefore likely to interact with the C-terminus of eIF3b. 
Another hypothesis is that the N-terminus of this peptides interacts with the 
unreported eIF3b(640-653) region, indicating the possibility that the N-terminus of 
eIF3bC3 bends towards the outer surface of blade 6 and 7 from eIF3i. 
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Figure 11 HDX of eIF3i(4-25). Top: mass spectra of the isotopic envelop of doubly charged 
ion from eIF3i monomer (left) and eIF3i in the complex (right) before deuteration (ref.) and 
after different times of deuteration. Bottom-left: highlight of the position of this fragment on 
the crystal structure. Bottom-middle: interacting regions with molecular details(eIF3i: green; 
eIF3b: blue) [1]. Bottom-right: Plot of deuteration levels as the average (square) of two 
replicates (triangle) against the deuteration time. Blue and green marks represent eIF3i 
monomer while red and purple marks represent eIF3i in the complex. 
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 Figure 12 HDX of eIF3i(288-300). Left: Plot of deuteration levels as the average (square) of 
two replicates (triangle) against the deuteration time. Blue and green marks represent eIF3i 
monomer while red and purple marks represent eIF3i in the complex. Right: highlight of the 
position of this fragment on the crystal structure.  
 
 
Figure 13 HDX of eIF3i(317-329). Left: Plot of deuteration levels as the average (square) of 
two replicates (triangle) against the deuteration time. Blue and green marks represent eIF3i 
monomer while red and purple marks represent eIF3i in the complex. Right: highlight of the 
position of the peptide on the crystal structure.  
The second hypothesis finds its co-evidence from eIF3i(317-329) (Figure 13). In eIF3 
monomer, eIF3i(317-329) shows low levels of deuteration as it consists of a β-sheet 
and a short α-helix. Decrease in deuteration levels is observed after complex 
formation. This leads to the similar hypothesis that it is protected via interaction with 
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 Figure 14 The change of deuteration level after different times of deuteration for eIF3i in 
three forms, color-coded on the crystal structure of eIF3i:b(654-700). Regions in yellow show 
increase in deuteration level, in white show no c hanges and green show decrease in 
deuteration level. 
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the N-terminus of eIF3bC3, as it is distant from the central cavity of eIF3i which may 
interact with the C-terminus of eIF3b. However, it is also possible that the α-helix in 
the C-terminus of eIF3i is less structured in the monomer, and the complex formation 
stabilizes this structure, protecting the distant residues in eIF3i(317-329) so that the 
deuteration level decreases.  
A summarized overview of the interacting regions is illustrated in Figure 14, where 
the change of deuteration level for each peptide before and after the complex 
formation is color-coded on the structure. Detailed interaction information that have 
been discussed above can be reviewed from this figure: regions near the central cavity 
of eIF3i interact with the C-terminal of eIF3bC3, the loops on blades 5 and 6 interact 
with the long α-helix in the middle of eIF3bC3, and the outer β-sheets on blades 6 and 
7 may involve in the interaction with the eIF3bC3 N-terminus.  
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2.3 HDX of eIF3i in complex with eIF3gC1ΔC 
Due to the limits of time, in this work only one data point of eIF3i:gC1ΔC(42-170)  is 
analyzed at each time point. The lack of replicates leads to the loss of deviation 
estimation for the deuteration level, and therefore a high threshold needs to be applied 
when considering the significance of the deuteration change upon complex formation. 
Nevertheless, since the experiments on eIF3i:gC1ΔC were taken continuously within 
one day, the instrumental condition remained highly stable, lowering the errors that 
may be induced during the experiments.  
 
Figure 15 HDX profile of eIF3i in the complex of eIF3i:gC1ΔC after (a) 5 s, (b) 1 min, (c) 15 
min, (d) 30 min of deuteration. Peptides are color-coded according to the deuteration levels.  
The same list of selected peptides as for eIF3i monomer and the eIF3i:bC3 complex 
was thoroughly verified. The deuteration level for each peptide is color-coded on the 
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protein sequence (Figure 15). Along the time course, the N-terminus of eIF3i, 
eIF3i(2-74) remains less deuterated, as well as the regions of 154-187 and 210-222. 
Regions of 80-107, 125-153, 188-209, 230-242 and 317-329 show medium-low 
deuteration levels, while regions of 108-124, 222-229 and 243-276 show high 
deuteration levels. Parts of these regions are similar to the changes observed on eIF3i 
in complex with eIF3bC3. This might indicate that the binding surface of eIF3b and 
eIF3g on eIF3i are close in space to each other, or that binding leads to similar 
changes in eIF3i dynamics.  
Similarly to the data processing of eIF3i:bC3, the deuteration levels of selected 
peptides in eIF3i from the complex of eIF3i:gC1ΔC are plotted on the structure model 
of eIF3i (Figure 6, right column). The inner parts of blades 2, 4 and 5 remain less 
deuterated even after long deuteration times, and this is coherent with the behaviors in 
eIF3i monomer and eIF3i:bC3. The rest of the structure shows different HDX in 
comparison with eIF3i monomer (Figure 6, left column), and these changes of solvent 
protection or destabilization reveal some clues on the binding of eIF3gC1ΔC and are 
discussed in details.  
In order to focus on the significant binding regions, the deuteration change of each 
peptide before and after complex formation is plotted in Figure 8 from data of 5 s and 
30 min reaction. Similar decreases in deuteration levels are shown in N-terminal 
residues 4-37 in eIF3i:gC1ΔC as in eIF3i:bC3, which may be caused by conformation 
stabilization upon the bindings. Such coincident decreases in both complexes are also 
observed in the regions of 195-211, 229-242, 271-282, 278-285 and 288-316. The 
region of 263-271 in eIF3i:gC1ΔC also exhibits a decrease of deuteration, however 
less significant than in eIF3i:bC3. These similarities in deuteration behaviour strongly 
support the primary hypothesis from Figure 15 and Figure 6 (right column) that the 
two complexes share close binding regions. On the other hand, several other peptides 
in the regions of 222-228, 251-277 and 317-329 exhibit no decreases in deuteration 
levels although their neighbouring peptides are less deuterated. These regions are 
informative to raise the spatial resolution of the binding region elucidation. 
Increases in deuteration levels are observed in various peptides in the regions of 87-
107 and 125-155 in eIF3i:gC1ΔC. Such significant increases occur exclusively in the 
presence of eIF3gC1ΔC. Figure 16 shows the locations of these regions on the crystal 
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structure as well as an unchanged region of 154-187, and the mass spectra of peptide 
eIF3i(125-154) (left) and eIF3i(154-187) (right) are shown in Figure 17 in different 
conformations after 30 min deuteration, as labelled on each spectrum. The spectra of 
these two peptides from the trimer of eIF3i:bC3:gC1ΔC are also extracted and shown 
here, although the complex has not been analyzed thoroughly yet. Clearly, in 
eIF3i:gC1ΔC (16.6%) as well as in eIF3i:bC3:gC1ΔC (17.0%), eIF3i(125-154) shows 
higher deuteration level than in eIF3i monomer (12.0%)  and eIF3i:bC3 (11.5%). 
Notably, the experiments of eIF3i:gC1ΔC and eIF3i:bC3:gC1ΔC were taken in May 
2013, while those of eIF3i monomer and eIF3i:bC3 were taken in December 2012 and 
January 2013. In order to distinguish the changes from instrumental errors, a 
neighbouring peptide, eIF3i(154-187), is similarly analyzed as a control example. The 
deuteration levels of eIF3i(154-187) in the monomer, the complex with eIF3bC3, the 
complex with eIF3gC1ΔC and the trimeric complex are 8.7%, 8.0%, 9.6% and 9.0%, 
illustrating that despite the experimental deviation, the deuteration change in the 
peptide eIF3i(125-154) is structurally significant. The change occurs in both 
complexes containing eIF3gC1ΔC, and this indicates that the binding of eIF3gC1ΔC 
leads to a destabilization of the region of eIF3i(125-155) located on the outer part of 
blade 3. Obviously, this region should not be at the direct binding surface, otherwise 
the deuteration should be prevented by the binding of eIF3gC1ΔC. However, it may 
be linked to the binding regions so that its conformation is influenced by the complex 
formation. 
 
Figure 16 Highlights of the positions of the peptides eIF3i(87-107), eIF3i(125-154) and 
eIF3i(154-187) on the crystal structure.  
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 Figure 17 Mass spectra of eIF3i(125-154) (left) and eIF3i(154-187) from different 
conformations (shown as labelled) after 30 min deuteration. 
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Besides this region, several other peptides which have significance in the structural 
elucidation of eIF3i:3g are analyzed in further details and the kinetic plots are 
generated. These peptides lead to more precise insights of the binding regions. 
 
Figure 18 HDX of eIF3i(38-62). Left: Plot of deuteration levels as the average (blue) of two 
replicates (green) for eIF3i monomer and one set of data for eIF3i:gC1ΔC (red) against the 
deuteration time. Right: highlight of the position of this peptide on the crystal structure. 
The HDX of eIF3i(38-62) is shown in Figure 18, where the deuteration levels 
decrease upon the binding of eIF3gC1ΔC. Such decreases of deuteration levels are 
also observed in eIF3i:bC3, which may be attributed to the interaction of the eIF3bC3 
C-terminus with the C-terminus of eIF3i(38-62) near the central cavity of eIF3i, or to 
the stabilization in the N-terminus of eIF3i in blade 1 upon binding with eIF3bC3. As 
the binding location of eIF3bC3 and eIF3gC1ΔC should not completely overlap, the 
interaction region of eIF3gC1ΔC is likely to be at the outer surface of blade 1 and the 
adjacent loops. On the other hand, it is also possible that the decreases are caused by 
structural stabilization, rather than by the direct binding of the two subunits. 
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 Figure 19 HDX of eIF(80-90). Left: Plot of deuteration levels as the average (blue) of two 
replicates (green) for eIF3i monomer and one set of data for eIF3i:gC1ΔC (red) against the 
deuteration time. Right: highlight of the position of this peptide on the crystal structure. 
Spatially close to the regions of eIF3i(38-62) is the peptide eIF3i(80-90) as shown in 
Figure 19, locating in the loop and outer β-sheet of blade 2 in eIF3i. In the kinetic 
plots in Figure 20 (left), no significant difference is observed after 15 min deuteration, 
but the exchange in the complex is slower than in the eIF3i monomer as shown by the 
data points at the short deuteration times. This region is, therefore, not likely to be the 
direct binding region.  
The peptides shown in Figure 20, 21, 22 and Table 1 together provide binding 
information on blades 5, 6 and 7 of eIF3i. As shown on the top of Figure 20, peptide 
eIF3i(223-228) exhibits no change in deuteration upon the binding of eIF3gC1ΔC, 
which can be clearly explained by the top-right structure model as the highlighted 
eIF3i(222-228) tightly binds to eIF3b(654-700), inhibiting the interaction of this 
region with eIF3g. The peptide of eIF3i(223-242), however, exhibits significant 
decreases in deuteration level in the complex. The kinetic plot for peptide eIF3i(229-
242) is not shown here as it is not present in all time points; yet it also shows less 
deuterated in some data points: 23.3% and 24.7% of deuteration are observed in the 
eIF3i monomer after 15 min and 30 min reaction, respectively, corresponding to 12.7% 
and 14.3% in eIF3i:gC1ΔC. The kinetic plots in Figure 20 and the partially observed 
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deuteration change in eIF3i(229-242) indicates the direct interaction in the outer β-
sheet of blade 5 and the long loop region between blades 5 and 6. 
 
Figure 20 HDX of eIF3i(223-228) (top) and eIF3i(223-242) (bottom). Left: Plots of 
deuteration levels as the average (blue) of two replicates (green) for eIF3i monomer and one 
set of data for eIF3i:gC1ΔC (red) against the deuteration time. Right: highlights of the 
position of the peptides on the crystal structure. 
The regions of eIF3i(251-285) is located on blade 6. Peptide eIF3i(251-262) is less 
deuterated in the complex (Table 1), whereas an increase in deuteration level is 
observed in the peptide eIF3i(251-273) (Figure 21, top and Table 1) as well as in the 
peptide eIF3i(251-277) (Table 1). There is no separate information for any peptides in 
263-277 (Figure 22, left), but by comparison of the information in Table 1, it is clear 
that peptide 251-262 is involved directly in the binding region, while 263-277, the 
unstructured loop and part of the β-sheet is destabilized by the complex formation. 
The peptide eIF3i(278-285) again exhibits lower deuteration levels in the complex 
124
(Figure 21, bottom). As this peptide is located on the same side of eIF3i(251-262) in 
blade 6, this co-supports the hypothesis that the binding of eIF3gC1ΔC occurs 
exclusively with the “left” part of blade 6.  
 
Figure 21 HDX of eIF3i(251-273) and eIF3i(278-285). Left: Plots of deuteration levels as the 
average (blue) of two replicates (green) for eIF3i monomer and one  set of data for 
eIF3i:gC1ΔC (red) against the deuteration time. Right: highlights of the positions of the 
peptides on the crystal structure. 
Table 1 Deuteration levels of selected peptides.  
 eIF3i monomer  eIF3i:gC1ΔC 
time 5 s 15 min 30 min  5 s 15 min 30 min 
251-262 14.7% 32.1% 32.8%  18.7% 25.2% 25.5% 
251-273 17.7% 31.5% 27.0%  24.3% 34.7% 35.4% 
251-277 16.5% 23.9% 23.7%  20.5% 26.3% 27.0% 
288-300 13.4% 21.3% 24.0%  11.3% 18.3% 17.7% 
299-315 13.5% 23.3% 26.4%  10.1% 16.1% 17.2% 
317-329 8.9% 12.2% 13.3%  8.0% 14.2% 13.9% 
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 Figure 22 Highlight of eIF3i(299-315) on the crystal structure. 
Peptide eIF3i(288-300) consists of part of the outer β-sheet of blade 6, the loop 
between blades 6 and 7 and the inner β-sheet of blade 7 (Figure 12, right), and it also 
exhibits significantly lower deuteration levels in the complex (Table 1). As 
demonstrated above with the evidence of eIF3i(263-277), it is not likely that the N-
terminus of 288-300 is in the binding region. Rather, as the C-terminal β-sheet 
structure locates close to eIF3i(251-262), it is more probable that this region interacts 
with eIF3gC1ΔC and causes the decrease of the deuteration level. The decrease in 
deuteration level in eIF3i(299-315) (Table 1) supports that the binding occurs in the 
inner side of blade 7 (Figure 22), while the similar deuteration levels before and after 
complex formation for peptide eIF3i(317-329) (Figure 13, right) indicates that the 
outer β-sheet and the short α-helix are not in the binding region.  
A summarized view of the HDX change upon the formation of eIF3i:gC1ΔC is shown 
in Figure 14 (middle column). It has to be noted that some details discussed above 
cannot be revealed directly due to the peptide-level resolution. Nevertheless, this 
figure provides a direct overview of the HDX change in the two forms of eIF3i. 
Intensive red regions are destabilized by the binding of eIF3gC1ΔC, e.g in blades 2 
and 3. White and pink regions are not involved in the interaction and do not change in 
the HDX behavior, whereas the blue regions show significant decreases in deuteration 
levels and should be in the binding surface.  
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2.4 Discussion 
The partial interaction map of eIF3i:b has been unveiled by X-ray crystallography [1], 
however the monomeric eIF3i has not been crystallized, and the binding information 
was only reported on a restricted fragment of eIF3b. In this work, HDX-MS first 
shows a possible conformation change of eIF3i upon complex formation with 
eIF3bC3. The “inner” blades 3 and 4 exhibit low deuteration levels along the time 
course, while the N- and C-termini show higher deuteration levels. This may be 
attributed to a higher flexibility at both termini, and a frequent open-close motion of 
the β-propeller structure of eIF3i monomer. 
The HDX behavior upon the complex formation of eIF3i:bC3 is coherent with the 
reported structure of eIF3i:b(654-700). The reported binding regions in eIF3i:b(654-
700) are significantly less deuterated, either due to the hydrogen bond formation or 
spatial shielding of eIF3bC3. In addition, there are several regions showing significant 
HDX changes which are not in the binding surface of eIF3b(654-700), and further 
interaction information of the eIF3b(640-653) and eIF3b(701-735) with eIF3i can be 
elucidated. The validated correlations between the structure model of eIF3i:b(654-700) 
and the HDX of peptides in known binding regions serve at this stage as the inner 
controls. The extended N-terminal fragments in eIF3bC3 may bend towards the outer 
surface of blades 6 and 7 in eIF3i, while the C-terminus of eIF3bC3 may interact with 
the central cavity of the eIF3i β-propeller and extend further towards blade 1. 
The complex of eIF3i:g still lacks atomic structure model from X-ray crystallography, 
nor is there any high-resolution EM information. However, it has been reported that 
the subunits of eIF3i, eIF3b and eIF3g each interacts with the others [7]. Therefore the 
binding surface of eIF3i:b and eIF3i:g may be close to each other. The HDX of 
eIF3i:gC1ΔC is coherent with this hypothesis: significant deuteration changes are 
observed in both complexes in blades 1, 5, 6 and 7. The known interaction sites of 
eIF3i with eIF3b are informative to unveil the interaction of eIF3g, as although the 
binding surfaces may be close to each other, the binding sites should be exclusive: 
one residue in eIF3i is not likely to bind with both eIF3b and eIF3g. Thorough 
analysis of the information from the above various methods provides some clues of 
the structure of eIF3i:gC1ΔC: eIF3gC1ΔC interacts with blades 1, the outer loop of 
blade 2, inner β-sheets of blade 7 and the “right” half of blade 6. It causes a 
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significant destabilization of blade 2 and 3, and it does not interact with blades 4 or 5, 
the “left” half of blade 6 and the outer β-sheet of blade 7.  
A comparison of deuteration upon the formation of eIF3i:bC3 and eIF3i:gC1ΔC is 
shown in Figure 14 (right column), with the previous comparisons between the free 
form of eIF3i and the complexes, as labeled on top of each structure. The interaction 
surfaces of the two complexes can be reviewed: regions in white are either not in the 
binding surfaces as in blades 2 and 4, or strongly interact with both eIF3b and eIF3g 
as in blade 1 and 7. Regions in blue shows that the deuteration levels decrease more 
significantly in eIF3i:bC3 and therefore is on its binding surface as in blades 4, 5 and 
6, or that there is an increase of deuteration level in eIF3i:gC1ΔC as in blade 3. 
Regions in red show stronger decrease in deuteration level in eIF3i:gC1ΔC as in 
blades 1 and 6, indicating that these are the exclusive binding regions of eIF3g. 
In summary, eIF3bC3 and eIF3gC1ΔC share close binding surface with eIF3i. They 
form a shell-like protection on both sides of blades 1, 5, 6 and 7, from the central 
cavity to the outer surface. Blades 2, 3 and 4 in eIF3i are not in the binding surface of 
either complex. This side of eIF3i is more likely to be the functional region as it 
remains accessible to other proteins.  
HDX-MS probes the structural information based on the different behavior of 
deuterium exchange for amide hydrogens at different locations. It correlates the 
protein structure with the HDX of given peptides, but is not possible to generate 
complete structure model or interaction map using only this method. However, with 
the help of even incomplete structural information provided by other methods such as 
X-ray crystallography, EM and native MS, HDX-MS can be powerful and sensitive to 
probe the interactions of protein complexes. 
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In this work, proteins were produced and purified by the author in our collaborating 
laboratory, the Biochemistry Laboratory in Ecole Polytechnique. The HDX-MS 
experiments were carried out in the host laboratory of DCMR. After deuteration and 
pepsin digestion, the peptide mixtures were desalted and separated using a nanoLC 
system, ionized by a nanoESI ion source and analyzed by a 7 T FT-ICR MS. 
The LC-MS/MS experiments were carried out in the Proteomics Platform in Pasteur 
Institute, Paris, using a LTQ Orbitrap Velos (Thermo Fisher) MS connected to a 
nano-HPLC Ultimate 3000 (Dionex). 
The instrumentation of the FT-ICR MS played an important role throughout the 
method development and data processing of this work, and is therefore discussed in 
details in this part. The other part of the instrumentation will also be described briefly. 
1 NanoLC system in HDX-MS 
The nanoLC instrument used in the HDX-MS part of this work consists of a home-
built double-valve column system connected to an Agilent Technologies 1100 Series 
nanoLC system. In the double valve system, the injection valve is a microsample 
injector (Rheodyne 7520) with a syringe port and an internal injection loop volume of 
0.5 µl.  It is connected to a 6 channel valve (Micro Valve Upchurch Scientific M-485) 
as shown in Figure 1. This second valve has a dead volumn of 35 nL. Silica capillaries 
(Polymicro Technologies) of two different inner diameters are used: 20 μm for the 
parts involved in the gradient (Figure 1, red) and 75μm for the remaining connections 
(Figure 1, blue). The valves are manually switched in order to inject the sample into 
the sample loop or load the sample from the loop onto the precolumn for valve 1, and 
change between washing the precolumn and elute the sample through the analytical 
column for valve 2. 
A Zorbax 300SB-C18 column, which is 5 mm long and 0.3 mm in internal diameter, is 
installed as the precolumn to desalt and concentrate the sample. The stationary phase 
of this column comprises octadecyl carbon chain (C18)-bonded silica particles with an 
average diameter of 5 μm. The analytical column is a Zorbax 300SB-C18 column of 5 
cm length and 0.075 mm inner diameter and the diameter of the silica particles in the 
stationary phase is 3.5μm. 
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Figure 1 Scheme of the double-valve system. 
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 Figure 2 Photo of the Agilent Technologies 1100 Series nanoLC system. 
The gradient is controlled by an Agilent Technologies 1100 Series nanoLC system 
(Figure 2). Inorganic solvent and organic solvent are separately degassed, and 
transferred to the nano pump where they are mixed according to the gradient. The 
Agilent nano-LC system is based on an active split of the primary flow generating the 
secondary nano-flow after mixing. 
The interface between the nanoLC and the FT-ICR MS, i.e. the nano-electrospary 
(nanoESI) is generated in a nanoESI source using PicoTip Emitter needles purchased 
from New Objective (Woburn, MA, USA), which has an outer diameter of 360μm, an 
internal diameter of 75μm and an outlet of 10μm for the spray formation. The sprayed 
ions are transferred into the FT-ICR MS and analyzed. 
2 FT-ICR MS 
FTMS, including FT-ICR MS and Orbitrap MS, has the highest resolution among all 
the modern MS techniques, which is crucial to this work. The FT-ICR MS was first 
introduced in 1974 by Melvin Comisarow and Alan Marshall [1], and nowadays with 
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the development of the instrumentation as well as the electromagnet it is playing an 
powerful role in various applications. Numerous reviews and textbooks have been 
published to introduce its principle, application and perspectives. [2-4] Here only a 
brief illustration of the instrumental principle and relevant evolution during this work 
will be presented in this part. 
2.1 The principles of FT-ICR MS 
FTMS is based on the technique of ion cyclotron resonance (ICR) mass spectrometry: 
a charged particle will precess in a magnetic field at a frequency depending on its m/z 
value [1, 3-4]. 
 
Figure 3 Precessing ion in a magnetic field. [3] 
The moving ion is subject to a force F�⃗  given by: 
𝐹�⃗ = 𝑞?⃗? ×𝐵�⃗                                 (1) 
where q, ?⃗? and 𝐵�⃗  represent the charge, velocity and uniform magnetic field, 
respectively. The ion moves in a circle with a radius (r) which is perpendicular to the 
magnetic field as shown in Figure 2, and the positive and negative ions orbit in 
opposite trajectories. If the opposite direction of the magnetic field is denoted as the 
z-axis, i.e. 𝐵�⃗ =  −𝐵0𝑘�⃗ , the ion velocity in the xy plane, vxy can be determined 
according to Equation 1 as  
𝑚𝑣𝑥𝑦
2
𝑟
= 𝑞𝑣𝑥𝑦𝐵0                                                           (2) 
with m as the mass of the particle. The angular velocity,ω (in rad/s), about the z-axis 
is defined as  
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𝜔 =  𝑣𝑥𝑦
𝑟
                                                             (3) 
so that Equation 2 can be deduced as 
𝜔 = 𝑞𝐵0
𝑚
                                                                   (4) 
and further as 
𝑣𝑐 =  𝜔𝑐2𝜋 =  1.535611 × 107𝐵0𝑚/𝑧                                                (5) 
Equation 5 is the so-called cyclotron equation, in which the frequency vc is in Hz, B0 
is in Tesla, m is in u and z is the charge state of the particle. Thus ions with the same 
m/z value have the same frequency vc given that the magnetic field remains constant, 
independent of their velocity. This is the essential feature that allows the ICR 
frequency to be used for m/z determination. 
According to Equation 2, the orbital radius is dependent on the velocity and the m/z. 
Ions of thermal energy have thus a radius: 
𝑟 =  1
𝑞𝐵0
√2𝑚𝑘𝑇                                                   (6) 
where k is the Boltzmann constant and T is the temperature in K. This indicates that 
the thermal radius is proportional to the square root of m and reciprocal to the 
magnetic field.  
However, the frequency is not readily detected if the ions oscillate at the thermal 
radius. A spatially uniform electric field oscillating at or near the ICR frequency has 
to be applied, in order to accelerate the ions to a larger orbital radius detectable by the 
detector (Figure 4, left). The excitation pulse makes the ions reach the same radius 
close to the detection plates, ensuring all ions to have coherent movement, which 
generate a current that is detected by the detection plates (Figure 4, right). The time-
domain ICR signals are Fourier transformed into frequency domain magnitude spectra 
that are, as demonstrated in Equation 5, reciprocal to m/z. 
The cubic cell was initially developed and widely used as the ICR cell, which consists 
of six plates arranged in a cubic shape, in three opposite pairs as the trapping, 
excitation and detection plates. In our instrument, a cylindrical cell is installed, in 
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which the trapping plates remain planar while the excitation and detection plates are 
cylindrical.  
 
 
Figure 4 Scheme of the excitation and detection in the ICR cell (top) [3] and illustration of a 
cylindrical ICR cell (from Bruker document). 
2.2 Factors ensuring the high performance of FT-ICR MS 
The resolution in FT instruments is usually defined as the full width of a spectral peak 
at half-maximum peak height, termed as Δm50% in mass-domain FT-ICR spectra. The 
resolving power is thus defined as m/Δm50%. Deduction of the above equations gives 
the expression of the resolving power: 
𝑚
𝛥𝑚50% =  − 𝑞𝐵0𝑚∆𝜔50%                                                            (7) 
where Δω50% is frequency domain resolution. The resolving power differs thus with 
the mass as well as the frequency resolution, the latter depending on the acquisition 
time. Thus the correlation of these factors can be illustrated as in Figure 5. Generally, 
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higher magnetic field and longer acquisition time leads to higher resolution for the 
FT-ICR MS, while the resolving power decreases with the increase of the mass. 
 
Figure 5 Correlation of the mass resolving power of FT-ICR MS with the magnetic field, m/z 
and acquisition time [3].  
2.3 The evolution of instruments during this work 
This work started in October 2010, with a 7 T FT-ICR APEX III mass spectrometer 
(Bruker, Germany). The instrument was upgraded to APEX Q (Bruker, Germany) in 
January 2011, and again upgraded to SolariX (Bruker, Germany) in April 2012, 
whereas the ICR cell and the magnet remained the same. Although as demonstrated 
above, it is the magnetic field of the ICR cell that primarily determines the resolution 
of the FT-ICR MS, the earlier stages of the instrument, including the ion source, the 
ion storage and transfer elements, are also crucial to achieve the high performance. 
2.3.1 APEX III  
In the initial APEX III instrumentation, ions formed by the nano-ESI source as 
described above are transferred, through a set of electrostatic lenses, to the center of 
the cell locating in the center of the superconductive electromagnet. A hexapole 
storage is inserted after the capillary in the ESI source, and before electrostatic 
transfer system, in order to accumulate ions before sending them into the ICR cell, 
where the ions are analyzed and detected by measuring the cyclotron frequency.  
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 Figure 6 Scheme of the FT-ICR APEX III MS. (From Bruker document) 
2.3.2 APEX Q 
The first instrumental upgrade was the replacement of APEX III by APEX Q hybrid 
q-FT-ICR instrument (Figure 6). Several features essentially increased the 
performance of the FT-ICR MS. An ion funnel system, located after the ESI source 
capillary allowed an improved transfer of the ions through the pressure restriction 
systems. A quadrupole was added in order to allow possible selection of parent ions. 
A collision hexapole was also added to allow CID fragmentation of the quadrupole 
selected parent ions. Significantly higher sensitivity was achieved upon this upgrade 
as demonstrated in Chapter 3: marginally larger numbers of ions were detected which 
led to an increase in the sequence coverage of the HDX analysis. 
2.3.3 SolariX 
In April 2012, a new generation Bruker SolariX package was installed to replace the 
APEX Q system (Figure 7). An orthogonal change of the ion transfer direction was 
introduced after the ion source, which reduces the population of neutral particles 
entering the ion funnel system. Also important for this work is the addition of a new 
hexapole ion guide as well as a second ion funnel which again increased the 
efficiency of the ion transfer.   
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 Figure 7 Scheme of the FT-ICR APEX Q MS. (From Bruker document) 
 
 
Figure 8 Photo (top) and scheme (bottom) of the FT-ICR SolariX MS (from Bruker document).  
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3 Experimental protocols 
Water used in this work was purified using a Millipore Direct-Q 3. D2O, acetic acid, 
formic acid, acetonitrile, pepsin and other chemicals were purchased from commercial 
suppliers of Sigma, Aldrich, Merck or Roth.  
3.1 Protein production and purification 
3.1.1 Production of eIF3i, eIF3bC3 and eIF3gC1ΔC 
The plasmid pET3a-lpa-eIF3i was transformed by electroporation into BL21(DE3)-
Rosetta competent cells (40 µL) and inoculated overnight in 1L 2xTY media at 18 °C. 
The next morning, 1 mM IPTG was injected to induce the expression of the eIF3i 
gene at 18 °C for one day. 
The plasmids pET32b-eIF3bC3 and pET15b-lpa-eIF3gC1ΔC were independently 
used to transform by electroporation BL21(DE3)-Rosetta competent cells. The 
transformed cells were used to inoculate autoinductible ZY media at 18 °C overnight. 
The cells were let grown 3 days until the turbidity of the media was high enough (Abs 
<= 6). 
The proteins of eIF3i and eIF3gC1ΔC have tags on the N-termini as shown in Table 1 
for the initial 20 residues, i.e. the wild-type protein sequences starts from the 21st 
residue. eIF3bC3 has a his-tag on the C-terminus, i.e. the last six residues shown in 
Table 1. 
Table 1 Sequences of the proteins. 
Protein / Mw Sequence 
eIF3i /  
40918.7 Da 
MGSSHHHHHHSSGLVPRGSHMKAIKLTGHERPLTQVKYNKEGDLLFSCSKDSSASV
WYSLNGERLGTLDGHTGTIWSIDVDCFTKYCVTGSADYSIKLWDVSNGQCVATWK
SPVPVKRVEFSPCGNYFLAILDNVMKNPGSINIYEIERDSATHELTKVSEEPIHKIITHE
GLDAATVAGWSTKGKYIIAGHKDGKISKYDVSNNYEYVDSIDLHEKSISDMQFSPDL
TYFITSSRDTNSFLVDVSTLQVLKKYETDCPLNTAVITPLKEFIILGGGQEAKDVTTTS
ANEGKFEARFYHKIFEEEIGRVQGHFGPLNTVAISPQGTSYASGGEDGFIRLHHFEKS
YFDFKYDVEKAAEAKEHMQEAN 
eIF3bC3 / MLREWSAQFEEQDAMEADTAMRDLILHQRELLKQWTEYREKIGQEMEKSMNFKIF
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11324.5 Da DVQPEDASDDFTTIEEIVEEVLEETKEKVELEHHHHHH 
eIF3gC1ΔC / 
16199 Da 
MGSSHHHHHHSSGLVPRGSHMEKVHKSVAERKNWHKYGSEKGSPAGPSAVTARLG
EEVELRLSRNWKQAEEERIQKEKASLTKTGLQCRLCGNDHMTMNCPFKTILSELSAL
EDPATNEGGVEAASEEKAGQVGGAGSIPGQYVPPSRR 
3.1.2 Protein purification 
- Cell extraction 
The harvested cells were centrifuged to separate from the supernatant, resuspended 
into the breaking buffer (10 mM MOPS at pH 6.7, 500 mM NaCl, 2 mM β-
mercaptoethanol, 0.1 mM PMSF and antiprotease cocktail, 30 mL for 1 L culture) and 
sonicated for 600s (1s pulse ON, 1s pulse OFF) to break the cell membrane. The cell 
extract was then centrifuged in a JA-20 rotor at 20 000 rpm at 4°C for 30 minutes. 
- FPLC purification and quality control 
An FPLC system from Biorad controlled by the BioLogic DuoFlow software was 
used to purify the proteins.  
A TALON (2 mL, Clonetech) column was equilibrated with buffer A (10 mM MOPS 
at pH 6.7, 500 mM NaCl, 2 mM β-mercaptoethanol, 25 mM imidazole). The 
supernatant was loaded on the TALON with 60 mL buffer A at a flow rate of 0.5 
mL/min, washed with 30 mL buffer A (15 column volumes) at 1 mL/min and the 
protein was then eluted with 20 mL (10 column volumes) of buffer B (10 mM MOPS 
at pH 6.7, 500 mM NaCl, 2 mM β-mercaptoethanol, 250 mM imidazole) at 1 mL/min. 
The eluted peak fractions were collected, and applied on a Q-Hiload equilibrated with 
the buffer (10 mM MOPS at pH 6.7, 500 mM NaCl, 2 mM β-mercaptoethanol) to get 
rid of nucleic acids (flow of 2.5 mL/min).  
The flow-through peak fractions of Q-Hiload was then concentrated by centrifugation 
at 4 °C to less than 5 mL using 20 mL centrifugation tubes of 10000MWCO or 
30000MWCO from Vivaspin. The sample was then applied on a Superdex75 column 
equilibrated with the buffer (10 mM MOPS pH 6.7, 200 mM NaCl, 2 mM β-
mercaptoethanol) and washed with 120 mL of the buffer at a flow rate of 0.4 mL/min. 
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The purities of the peak fractions corresponding to the protein of interest were 
controlled by SDS-PAGE gel after each TALON and Superdex75 column.   
The samples were then concentrated to 50-150 mM by centrifugation at 4 °C using 5 
mL centrifugation tubes of 10000MWCO or 30000MWCO for the HDX-MS 
experiments, and the concentrations were estimated by the UV-absorbance at 280 nm 
using Nano Drop 1000 UV-Vis spectrometer. 
3.1.3 Complex purification 
eIF3i:bC3, eIF3i:gC1ΔC and eIF3i:bC3:gC1ΔC were produced by mixing the 
independently purified proteins. The same Superdex75 column was then used to 
purify the complex mixture containing the protein complex and the excess of one of 
the proteins (usually the one with smaller size to ensure larger difference in retention 
times). The complex peak fractions were collected, controlled by SDS-PAGE, and 
concentrated to 50-150 mM for the HDX-MS experiments. 
3.1.4 Protein storage 
Purified proteins were stored in buffer solution (200 mM NaCl) at -20 °C. Thaw-
freeze cycles were avoided, i.e. once the proteins were thawed for HDX-MS 
experiments they were consumed freshly and not frozen again. 
3.2 Hydrogen/deuterium exchange reaction  
Protein samples were diluted 1:20 with 200 mM NaCl D2O solution, and incubated on 
ice for different times: 5 s, 30 s, 1 min, 2 min, 4 min, 8 min, 15 min, 30 min, 3 h, 5 h, 
7 h, 24 h. The deuteration reaction was quenched by mixing 22.5 μL of the deuterated 
proteins solution with 22.5 μL of 6% acetic acid H2O solution on ice. 5 μL of 40 µM 
pepsin in H2O solution was added to digest the protein and the peptide mixture was 
injected into the nanoLC system for separation. 
3.3 NanoLC-MS  
The nanoLC workflow was optimized in the previous PhD work [5], as shown in 
Figure 8. Solvent A (0.5% formic acid H2O solution) and solvent B (0.5% formic acid 
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in a mixed solvent of H2O and acetonitrile (10 : 90)) were used in the LC gradient 
(Table 1). In order to minimize delays due to dead volumes in the pumps / split / 
nanoflow sensor and capillaries circuit, the LC gradient was started before the sample 
was prepared: thus two minutes before the pepsin digestion, the nanoLC run was 
started. The protein digest was injected at 6.5 min and started to be loaded onto the 
precolumn at 7 min, and after the 2 min wash it started to be eluted through the 
analytical column at 9 min.  
The MS acquisition triggered by the LC system was started at 10 min, with detailed 
parameters shown in Table 2. Peptide signals began at around 15 min in the LC time 
scale (which means 13 minutes after digestion started) and ended at around 40 min. A 
25 min wash with Solvent A ensured the elution of possible carry-overs and prepared 
the columns for the next run. 
Data of both reference samples and deuterated samples were acquired in the same 
condition and processed as described in Part II. 
 
 
 Figure 9 Time course of a whole nanoLC run, including the various stages of the experiment. 
 
 
147
Table 2 NanoLC gradient in HDX-MS experiments. 
Time / min Solvent B / %  Time / min Solvent B / % 
0 5  35 100 
25 50  36 5 
26 100  60 5 
 
Table 3 Parameters used in the acquisition by FT-ICR MS. 
Ion source  Acquisition and accumulation 
Capillary -850 V  Detection mode Broadband 
End plate offset 0 V  TD (Acquisition) 128 k 
Dry gas 4.0 L/min  Mass range 498 – 2000 
Drying gas 
temperature 
120 °C  
Estimated resolving 
power 
41000 (at m/z 400) 
  Average spectra 1 
   Source accumulation 0.01 s 
   
Ion accumulation 
time 
0.1 s 
   Ion cooling time 0.01 s 
   Time of flight 0.9 ms 
3.4 LC-MS/MS  
The LC-MS/MS experiments on the reference protein digests were carried out in a 
nano-HPLC-Orbitrap system. Proteins were diluted to 5 µM in 3% acetic acid, and 40 
µL of the diluted protein samples were digested by 5 µL pepsin solution of 40 µM. 5 
µL of the protein digests were injected to the HPLC system, separated and analyzed in 
the following condition: 
The 2-hour LC gradient is shown in Table 3, with the solvent A composed of water: 
acetonitrile: formic acid (98: 2: 0.1%) and solvent B of water: acetonitrile: formic acid 
(20: 80: 0.08%) at a flow rate of 0.3 µL/min. Such a long gradient was required to 
achieve maximal coverage in terms of number of peptides, but of course it is not a 
gradient accessible for an HDX experiment. 
The MS spectra were acquired with a m/z range of 300 – 2000. The top 20 peaks with 
signal intensity above 5000 in each MS spectrum were selected for MS/MS 
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fragmentation, using CID with isolation width of 2 Da and a normalized collision 
energy of 35 V. 
Table 4 HPLC gradient in LC-MS/MS experiments. 
Time / min Solvent B / %  Time / min Solvent B / % 
0 2  109 99 
3 2  110 2 
98 55  120 2 
99 99    
 
LC-MS/MS peak lists were extracted and submitted to a Mascot search with the 
following criterion: no specific enzyme, oxidation as variable modification, 10 ppm 
peptide tolerance, 0.5 Da fragment tolerance. The Mascot results were viewed using 
Scaffold Viewer, and the peptides with MS/MS of Mascot ion scores higher than 20 
were considered valid. 
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The initial objective of the thesis was to obtain HDX data on the eIF3 translation initiation 
complex. The long term objective was to reach a s tage at which analysis of the entire eIF3 
complex composed of 5 sub-units would be feasible. Of course this was an ambitious goal 
and the methodology was not yet available in the laboratory to reach such a goal. In the 
current work, progress was done on the binding regions between only three subunits eIF3b, 
eIF3g and eIF3i. 
One of the challenges met in the course of this work is related to changes in instrumentation: 
not less than three FT-ICR hardwares were used in the course of this work. These changes in 
hardware have impeded data acquisition: it proved necessary to complete a whole series of 
measurements on the same version of mass spectrometer, since the changes in sensitivity and 
mass accuracy meant that the reference list and data analysis had to be adapted for each 
change in instrumentation. On the other hand, these hardware changes also helped in 
improving the data analysis steps: improved sensitivity meant a large increase in the number 
of peptides that could be analyzed, thus leading to improved sequence coverage with more 
overlapping peptides. This led to the proposal of a new peptide assignment scheme, based on 
mass accuracy and a p robability of occurrence (POc) scoring system. These steps were 
absolutely necessary: as shown in Chapter 3, the increase in system size would have 
necessarily led to an increase in the total number of peptides and therefore an increase 
number of instances for which mass accuracy alone would not be sufficient for peptide 
assignment. This work has also shown that sensitivity leads to a huge number of 
monoisotopic peaks that are present in a single pepsin digest (over 1600 for the eIF3i:3bC3 
complex) Of course, all these peaks do not belong to pepsin digest peptides, but still a fairly 
large number of peptides (300) can be identified within this digest.  
As shown in Chapter 3, progress in instrumentation has also led to a large improvement in 
mass accuracy. Although FT-ICR mass spectrometry is regularly cited as a v ery accurate 
mass measuring equipment, there are some limitations, which are oftentimes overlooked. One 
such limitation is the space-charge effect, which occurs when the number of ions present in 
the cell reaches an upper limit. In the pepsin digests, a very large distribution of peak 
intensities was observed. Thus a compromise had to be done between keeping the ion 
accumulation time at a low level, and thus missing low intensity peptides but keeping high 
mass accuracy, or using a long accumulation time with better peptide coverage but lower 
mass accuracies. The internal calibration procedure used in this work could not cope with this 
problem, as the calibration ions (pepsin self-digest peptides) are not present in every 
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spectrum of the whole chromatogram. The most recent instrumentation (SolariX) has a new 
electronics system, which improved the management of space charge effects by increasing 
cell sensitivity. This led to a large improvement in mass accuracy over the whole 
chromatogram, and a narrow mass distribution is now achieved (see Chapter 3). Further 
improvements now require that the analysis software are able to make efficient use of this 
sub-ppm mass accuracy in processing HDX data: as stated in Chapter 3, the current data 
processing scheme is limited by the (13C – 12C) vs (2H-1H) mass difference. The Marshall 
group have proposed a clever solution to this issue [1], but it will require adapting our current 
data processing software. 
From a biological point of view, this thesis has helped progress in the deciphering of the 
interaction regions between eIF3i, eIF3g and eIF3b. As detailed above, parallel work [2] has 
achieved a crystal structure for eIF3i with a truncated form of eIF3b. Our work is well 
correlated with these results and can provide the basis for understanding the binding between 
eIF3i and eIF3g, for which very few is known. At the point of writing this manuscript, the 
data for the eIF3b:eIF3g:eIF3i complex are still under acquisition. Based on a few points, it is 
possible to extract the fact that most of the total structure is not strongly perturbed in the 
ternary complex, but hopefully we could reach is a complete picture within a few months. 
Based on our  results on both the potential binding sites but also on t he exchange kinetics 
which reflect the dynamics and structure of proteins in solution, our biologist collaborators 
are preparing new protein constructions, hoping to be able to obtain crystals that could lead to 
a crystal structure of this binding region.  
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